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The human placenta is the key interface at which the maternal immune system interacts 
with the semi allogeneic fetus. It is known that fetal cells can cross into the placenta into 
the maternal circulation, and that during pregnancy the maternal immune system is able 
to induce a potential cytotoxic response to fetal antigens. However, the complex 
equilibrium of immune tolerance at the maternal-fetal interface is maintained by a range 
of modifications to the local and systemic maternal immune system, which leads to 
protection of the fetus from the maternal immune response.   
Lymphoid infiltration is seen at the implantation site at the maternal-fetal interface, 
and decidual Natural Killer (NK) cells have been demonstrated to facilitate extravillous 
trophoblast (EVT) invasion into maternal decidua during the first trimester, facilitating 
haemochorial placentation. However, although there is also considerable T cell infiltration 
of the maternal decidua during pregnancy, the functional properties of this T cell response 
remain poorly defined. Indeed, a widely reported pathology of pregnancy, Villitis of 
Unknown Etiology (V.U.E), is associated with massive inflammatory invasion of cytotoxic T 
cells, causing detrimental fibrosis of the placental villi. This can lead to intrauterine growth 
restriction, fetal death and perinatal morbidities (Redline et al 2007).  
To further investigate the role of T cells that have infiltrated the maternal-fetal 
interface, and how they respond to the semi allogeneic fetus, we investigated the 
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phenotype, functionality, specificity and regulation of CD4+ and CD8+ T cells obtained from 
healthy human third trimester placenta, and compared these with matched maternal 
peripheral blood lymphocytes and cord blood.  We demonstrated that there are large 
populations of highly differentiated effector CD4+ and CD8+ T cells at the decidua in 
comparison to peripheral blood.  These cells also displayed a unique functional profile with 
simultaneous production of interferon-γ (IFN-γ) and interleukin (Il-4). Decidual T cells had a 
significantly increased proliferative response to fetal tissue, and HY-specific T cells were 
detectable in the decidua of women with male pregnancies. Fetal-specific T cells expressed 
high levels of Programmed Death Protein 1 (PD-1) and depletion of T regulatory cells led to 
an increase in fetal-specific proliferation, suggesting a dual mechanism of T cell regulation. 
Finally, transcriptional analysis of CD4+ and CD8+ decidual T cells revealed a unique gene 
profile characterized by elevated expression of proteins associated with the response to 
interferon signalling, as well as regulatory response pathways.  
Together, these findings have considerable importance for the study of healthy 
placentation and, furthermore, provide insights into the etiology of allo-reactive immune 
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1.1. The Adaptive and Innate immune response  
 
The human immune system is principally comprised of the Innate immune system and the 
Adaptive immune system. Innate immunity is stimulated almost instantly following 
recognition of allo-antigens, often in the form of invading pathogens, or in a clinical setting 
during allo-graft transplantation. Leukocyte components of the Innate immune response 
include phagocytic dendritic cells (DCs), macrophages, neutrophils, basophils and 
eosinophils, and cytotoxic natural killer (NK) cells (Janeway & Medzhitov 2002). Upon 
receptor binding, these cells are stimulated to phagocytose or release cytotoxic molecules 
to lyse target cells. Phagocytic leukocytes, such as dendritic cells, will process antigens 
following phagocytosis, and present these to the components of the adaptive immune 
response. NK cells detect aberrant MHC molecules, such as non-self MHC, and release 
cytotoxic cytokines. Together, the innate immune system sets an inflammatory response in 
motion.  
 The adaptive immune system works in synergy with the innate immune system to 
provide an almost immediate primary response (and secondary responses) to subsequent 
infections and allo-recognition. The adaptive immune system is primarily composed of T 
cells and B cells. These two cell types must be primed and tailored to specific aberrant or 
foreign antigens before being able to induce a response and undergo expansion and 
proliferation. Once activated these cells are able to directly affect or induce the killing of 
target cells. A proportion of the adaptive immune cells will form a “memory” subset, 
already primed to specific antigens, and are able to generate a rapid inflammatory 
response to secondary exposure to the allo-antigen. 
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 Antigen processing, presentation and recognition is key to developing a fully 
functional immune response. The Major Histocompatibility Complex (MHC) which displays 
processed antigens, plays a pivotal role in antigen presentation. MHC molecules are 
separated into two classes: MHC class I and MHC class II. Class I are expressed on almost all 
nucleated cells, and present peptides derived from intracellular antigens. In humans, MHC 
class I molecules include Human Leukocyte Antigen (HLA) -A, -B, -C and also specifically on 
fetal trophoblast, HLA-G (Gregori 2016) . CD8+ T cells that have been primed to a specific 
antigen are able to bind via their T cell receptor to MHC class I presented peptides. Once 
bound with additional co-stimulatory markers, CD8+ T cells are able to elicit a cytotoxic 
response. MHC class I molecules can also present exogenous antigen via cross-
presentation performed by antigen presenting cells (APC). MHC class II molecules are 
presented on specialised APCs, including dendritic cells, macrophages and B Cells. MHC 
class II molecules include HLA-DR, -DQ and -DP. MHC class II molecules often present 
peptide derived from endocytosing extracellular antigens. Once an antigen is captured and 
processed, APCs can migrate to lymph nodes where they present the antigen via MHC class 
II to CD4+ T cells (Roche & Furuta 2015). Figure 1.1 summarises the differences between 




















Briefly, MHC class I molecules present peptides that are derived from proteins degraded 
predominately in the cytosol, which comprise almost exclusively endogenous proteins. MHC 
class II molecules expressed by antigen presenting cells present endogenous and exogenous 
derived antigens. MHC class II molecules acquire peptide cargo that is generated by 
proteolytic degradation in endosomal compartments. The precursor proteins of these 
peptides include exogenous material that is endocytosed from the extracellular 
environment, and also endogenous components, such as plasma membrane proteins. 
Antigen presenting cells can also present exogenous antigen to CD8 + T cells through MHC 
class I via cross presentation however the mechanism involved are still poorly understoond. 






Figure 1. 1 MHC-peptide complex presentation pathways 
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1.2. T cell development  
 
T cells are derived from haematopoietic stem cells (HSC), which are produced in bone 
marrow.  Haematopoietic precursors that migrate to the thymus undergo T cell maturation 
and develop into naïve T cells. Lymphoid committed HSC that enter the thymus lack TCR, 
CD4 and CD8 expression. As they progress through the outer cortex they rearrange α and β 
TCR chains to a complete αβTCR and become CD4 and CD8 double positive. They next 
interact with thymic cortical epithelial cells, which present self-antigens via both MHC class 
I and II. Depending on which MHC molecule they bind, and provided correct TCR/co-
receptor signalling is successful, T cells mature into single positive CD4+ or CD8+. T cells 
that are unable to recognise the MHC peptide complex undergo apoptosis. This stage is 
known as positive selection. Single positive CD4+ and CD8+ T cells then traffic to the 
medulla where they encounter medullary epithelial cells or DCs. Here, T cells are again 
subject to self-antigen presented via MHC molecules. T cells that bind to these complexes 
with high avidity undergo apoptosis. This stage is known as negative selection. Once 
complete, the T cells that have passed both rounds of selection, are then able to leave the 
thymus and circulate as naïve T cells. Mature naïve T cells can be primed in lymph nodes by 
antigen presenting cells, such as DCs. Upon antigen presentation and co-stimulatory 
signals, CD4+ and CD8+ T cells will begin differentiation and upregulation of activation 
markers and cytokines (Zúñiga-Pflücker 2004).  
When primed T cells are able to form interactions with their cognate antigen on the 
target cell and they initiate an activation response. An immunosynapse forms at the site of 
activation, which involves TCR, CD3, CD4/CD8 and additional co- receptor interactions with 
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the target cell. CD4 and CD8 will interact with the corresponding MHC allele to stabilise 
antigen stimulation. Co-stimulatory signals are critical for a fully functional T cell response. 
TCR engagement in the absence of co-stimulatory signals can lead to anergy of the T cell 
resulting in inefficient cytokine expression and activation (Huppa & Davis 2003).  
 
1.3. T cell subtypes 
 
Effector CD4+ T cells are primarily comprised of Type 1 helper cells (Th1), Th2 and Th17 
subsets, each defined by a set of transcription factors, which allows them to reach a 
particular differentiated state. CD4+ differentiation state is often determined by the 
cytokine environment in which they are situated once activated. They may be also defined 
by their cytokine expression, related to their individual effector function. In addition each 
subset expresses chemokine receptors that directs their recruitment to inflammatory sites, 
where specific tissues will express different chemokine ligands (Zhu & Paul 2008). Figure 
1.2 illustrates the different chemokine, cytokine and transcription factors that are 
associated with different T cell subtypes.  
 Th1 cells express T-bet and signal transducer and activator of transcription (STAT) 4 
as their signature transcription factors, and secrete interferon- γ (IFN-γ) as their dominant 
cytokine, as well as tumor necrosis factor (TNF)-α, interleukin (IL-2) and lymphotoxin-α. 
They also express CXCR3 as their main chemokine receptor. Their key role is to eradicate 
virus infected cells and intracellular pathogens. Expression of IFN-γ promotes macrophage 
activation and also endothelial cell expression of the chemokines CXCL9, CXCl10 and 
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CXCL11, which are all ligands for the chemokine receptor CXCR3. They are therefore able 
to elicit their own recruitment, as well as recruitment of cytotoxic T cells to sites of 
inflammation (Nakanishi et al. 2009). Due to Th1 roles in surgical allo-graft rejection, it is 
thought that they may play a significant role in driving rejection of the fetus in some 
pathologies of pregnancy.  
 Th2 cells express GATA3 and STAT6 as their signature transcription factors, along 
with cytokines IL-4, IL-5 and IL-10 and chemokine receptor CCR4. Their primary function is 
regulation of antibody switching in areas of allergic inflammation and destruction of 
helminths. Th2 are seen to be highly relevant in maintenance of pregnancy due to their 
less cytotoxic cytokine profile and their ability to inhibit Th1 differentiation. This gives rise 
to the often cited paradigm of Th2:Th1 skew during pregnancy, to minimize cytotoxic 
damage by Th1 cells (Saito et al 2010).  
 Th17 cells express receptor-related orphan receptor-γ (RORγt), STAT3 and 
interferon regulatory factor (IRF) 4 as their signature transcription factors, along with 
cytokine IL-17 and chemokine receptor CCR6. Their main function is to enhance an 
inflammatory response to extracellular bacteria and fungi. IL-17 induce epithelial cells to 
express CXCL1, which attracts neutrophils to sites of inflammation, and neutrophil survival 
factor granulocyte colony stimulating factor (G-CSF). 
 CD8+ T cells, otherwise known as cytotoxic T cells share their characteristic 
properties with Th1 cells. They express transcription factors T-Bet and STAT4 as well as 
cytokines IFN-γ and TNFα and chemokine receptors CXCR3 and CCR5. Their main function 
is to eradicate intracellular pathogens by expressing the cytolytic molecules perforin and 
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granzyme. These cytolytic molecules are released upon binding of TCR to MHC-class I 
peptide complexes. Trophoblast down regulate MHC class I molecules on their surface, 
thereby limiting CD8+ T cells potential for allo-reactivity (Madeja et al. 2011). It has been 
suggested that DC and macrophage derived IL-12 and IL-18 can induce IFN-γ secretion by 
CD8+ T cells in a TCR independent pathway (Freeman et al. 2012) and their potential for 
detrimental cytotoxic activity in the decidua should not be discounted.  
 
1.4. Effector T cell differentiation 
 
Once an antigen-presenting cell presents pathogenic or aberrant antigen to naive T cells, T 
cells become activated, proliferate, and differentiate into effector cells which migrate to 
the site of infection or inflammation. The effector cells are short-lived, whilst memory cells 
are formed with the potential for long term survival (Golubovskaya & Wu 2016). Central 
Memory cells can be located in the secondary lymphoid organs, whilst Effector Memory 
cells reside in peripheral tissues. During re-exposure to their cognate antigen these 
memory T cells undergo rapid expansion and assist in the secondary immune response. 
CD8+ and CD4+ T cells can be divided into four subsets based on the expression of CD45 
and the chemokine receptor CCR7. These are categorised as: naïve (CD45+ CCR7+), Central 
Memory (CD45RA-CCR7+), effector memory (CD45RA- CCR7-) and CD45RA revertant 
effector memory, otherwise known as EMRA ( CD45RA+ CCR7-) (Sallusto et al. 1999). CCR7 
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is a chemotaxic receptor and its expression on central memory and naïve CD8 subsets is 
essential for migration to lymphoid tissue. Effector memory and EMRA subsets lose CCR7, 
which allows for their migration to peripheral tissue. CD45 has two isoforms, CD45RA 
expressed on naïve cells, which is then spliced into the second isoform CD45RO, following 
activation. EMRA CD8 subsets re-express CD45RA following activation and extensive cell 
division. This highly differentiated subset is, however, still cytotoxic. Expression of CD57 is 
a marker of cell differentiation and a proxy for telomere length, where naïve subsets are 
characterised by low CD57 expression, whilst EMRA subsets have a high CD57 expression 
(Brenchley et al. 2003). Effector memory subsets can be further sub-divided based upon 
the expression of co-stimulatory markers CD28 and CD27, where CD27- and CD28- are 
classed as having a high potential for cytolytic activity with expression of perforin, 
granzyme and IFN-γ (Romero et al. 2007). 
 
1.5. Regulatory T cells 
 
Despite negative and positive selection in the development of T cells, not all self and 
aberrant antigens will be presented by thymic and medullary epithelial cells and DCs in the 
thymus.  There are therefore additional peripheral mechanisms of tolerance. One aspect of 
this peripheral tolerance is the immunomodulatory CD4+ T regulatory cells. These 
specialised T cells negatively regulate effector CD4+ and CD8+ T cells during inflammatory 
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responses to self and foreign antigens. The variety of suppressive mechanisms by CD4+ T 
regulatory cells include: i). expression of inhibitory cytokines IL-10 , transforming growth 
factor β (TGFβ) (Joetham et al. 2007) and  vascular endothelial growth factor (VEGF) 
(Facciabene et al. 2011); ii). absorption of IL-2, which induces effector T cell apoptosis 
(Pandiyan et al. 2007) and iii). interaction with APCs, leading to a down-regulation of the 
their co-stimulatory markers (Qureshi et al. 2011), or with DCs, increasing expression of 
indoleamine 2,3- dioxygenase (IDO) (Fallarino et al. 2003).  
Two subsets of T regulatory cells are believed to exist: the thymus derived T 
regulatory cells, which have high avidity to self-MHC complexes, are thought to maintain 
tolerance to self-antigens in the periphery; and the peripheral or induced T regulatory 
cells, which are generated from peripheral naïve T cells and are thought to have more 
restricted TCR to modulate the immune response to specific foreign antigens (Sakaguchi et 
al. 2010). 
T regulatory cells are often characterised by their duel expression of CD25+ and 
transcription factor forkhead Box P3 (FOXP3). However, as these markers can also be 
expressed by non-regulatory activated CD4+ T cells, additional markers are often used to 












Summary of different cytokines and factors that influence CD4+ T cell 
differentiation upon interaction with APCs. Th1 are defined by the transcription 
factor Tbet and expression of IFNγ. Th2 are defined by transcription factor 
Gata-3 and expression of IL-4. Th17 are defined by RoRγt and the expression of 
IL-17. CD4+ T regulatory cells are defined as being FOXP3+ along with 
expression of IL-10.(Russ et al. 2013) 
 
Figure 1. 2 CD4+ T cell differentiation 
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1.6. Establishment of pregnancy 
 
Mature oocytes reside in the ampulla region of the oviduct. A fertilised oocyte travels from 
this region to the uterus, whilst undergoing compaction and cleavage. A morula is formed 
comprising of internal and external mass cells. The internal mass forms the embryo, whilst 
the external mass differentiates into the trophectoderm, which, in turn, forms the 
trophoblast cells of the placenta. During a process called cavitation the trophoblast cells 
form the blastocoel. The blastocoel grows and forms the blastocyst, which is implanted 
into the maternal endometrium (Cha et al. 2012). Once implanted, the trophoblast cells 
grow and differentiate into different cells types in parallel to the growing embryo and 
fetus. At the point of implantation, the maternal endometrium differentiates into the 
decidua, where fibroblasts of the uterine stroma transform and accumulate lipids and 
glycogen. At the point of direct contact with the trophoblast cells the decidua is known as 
decidua basalis, whilst the decidua parietalis forms from the remaining uterine wall.  
Following implantation, the developing placenta is fixed into position by anchoring 
chorionic villi, whilst floating villi form the large surface area trophoblast labyrinth for 
gaseous and nutrient exchange. Villi are comprised principally of two cell types: 
mononucleated cytotrophoblast which form an “endothelial” layer, and multinucleated 
syncytiotrophoblast which an “epithelial” layer (Lunghi et al. 2007). Following implantation 
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of the blastocyst, some cytotrophoblast penetrate through the syncytiotrophoblast layer 
and attach to the uterine wall forming cytotrophoblast columns and extravillous 
trophoblast cells (Huppertz & Peeters 2005). These invasive extravillous trophoblast cells 
migrate through the decidua and reach the maternal spiral arteries of the maternal 
endometrium, and replace the endothelial cells of the arterial vessel walls. The maternal 
spiral arteries now provide a continuous blood flow via the transformed vessels and 
cytotrophoblast columns (Craven et al. 2000). Figures 1.3 and 1.4 illustrate the early and 







A) After implantation, progenitors  of the trophectoderm give rise to the primitive 
syncytium by cell fusion. In this region lacunae, the ancestor of the intervillous space, 
are formed. B) Later, proliferative cytotrophoblasts (CTBs) derived from the 
trophectoderm, break through the primitive syncytium and contact the basal plate 
forming primary villi. C) Tertiary villi are built upon migration of extraembryonic 
mesodermal cells into the primary structures and vascularization. At distal sites, 
proliferative cell columns are formed which give rise to different invasive extravillous 
trophoblast subtypes. iCTBs migrate into decidual stroma where they approach 
vessels from outside and eventually form giant cells as the end stage of the invasive 
differentiation pathway. Endovascular trophoblasts migrate into spiral arteries and 
contribute to uNK cell-initiated tissue re-modelling within the decidua and the upper 
part of the myometrium.  
AE, amniotic epithelium; CCT, cell column trophoblast; DF, decidual fibroblast; EB, 
embryoblast; EM, extraembryonic mesoderm; eCTB, endovascular cytotrophoblast; 
GC, giant cell; ICM, inner cell mass, iCTB, interstitial cytotrophoblast; LUE, luminal 
uterine epithelium; L, lacunae, pF, placental fibroblast; PS, primitive syncytium; pV, 
placental vessel; SA, spiral artery; S, syncytium; TE, trophectoderm; UG, uterine gland; 
uNK, uterine NK cell; UV, uterine vessel; vCTB, villous cytotrophoblast. 
(Knöfler & Pollheimer 2013) 
 





















A) Decidual spiral arterioles perfuse the chorionic villi that line the intervillous 
space. B) In floating villi (FV), a continuous layer of multinucleated 
syncytiotrophoblast (SynT) interfaces with maternal blood. Beneath lies a 
progenitor population of mononuclear villous cytotophoblast (vCTB). At the 
uterine wall, invading cytotrophoblast (iCTBs) differentiate along the invasive 
pathway to form anchoring villi (AV) along with formation of the decidual layer 
(Zeldovich & Bakardjiev 2012) 
Figure 1. 4 Later stages of placentation and decidualisation. 
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It is important to address the sites at which the maternal immune system interacts directly 
with the placenta. The first site, which is concentrated on throughout this thesis, is within 
the decidua. It is at this site that immune cells including NK cells and T cells interact with 
invading extravillous trophoblast. This interaction allows for comprehensive engraftment 
of the placenta to uterine tissue and facilitates alterations to maternal spiral arteries to 
provide maternal blood to the intervillous space. Extravillous trophoblast express a 
restricted repertoire of HLA class I molecules, HLAC-C, G and E. Allo-reactive responses 
directed against extravillous trophoblast by T cells within the decidua will therefore be 
governed by interactions with these MHC molecules. The second site where maternal 
leukocytes can interact with the placenta is within the inter villous space. Maternal 
leukocytes are transported to the intervillous space through the supply of maternal blood 
via maternal spiral arteries, flooding the intervillous space. T cells within the intervillous 
space should not be able to interact or elicit an allo-reactive response to floating placental 
villi, as syncytiotrophoblast lack any MHC molecules. Figure 1.5 illustrates the differences 
in T cell interactions between these two sites. The interaction of maternal T cells with 
placental trophoblast is distinct at these two sites, and therefore any developmental or 
pathological outcome of these interactions will be discussed in context of this throughout 











































































































































































































































1.7. Immune modulation and immune tolerance during gestation 
 
The mechanisms that control maternal immune tolerance have not been fully elucidated, 
however, the consensus is that a combination of the maternal immune system, hormones, 
pregnancy cytokines and chemokines as well as cellular interactions of the fetal 
trophoblast play an important role.  These mechanisms have a direct impact on pregnancy 
success and the quality of outcome.  
From a historical perspective, Peter Medawar attempted to put forward his 
theories and hypothesis of why the semi-allograft fetus was not rejected by the mother 
(Medawar 1953; Ribatti 2015) . The three key aspects postulated for this immune 
modulation were: the inertness of the maternal immune system; the immaturity of fetal 
antigens; and the physical separation of the mother and fetus. Today, these early 
hypotheses have been largely disproven. The fetal trophoblast of the placenta is in direct 
contact with maternal blood, and there is constant transfer of reactive antigens to T cells 
of the maternal immune system (Zenclussen et al. 2007). Pregnancy is an active adaptive 
mechanism towards tolerance of the semi-allogeneic fetus, both locally at the intrauterine 
interface and in the peripheral immune system (Khosrotehrani et al. 2005).  
 During pregnancy the maternal immune system undergoes several phenotypic 
changes that coincide with  the growth of the semi-allogeneic fetus. Whether these 
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changes are necessary for the tolerance of semi-allogenic tissue is not fully understood. 
The syncytium of floating villi is devoid of MHC Class I, therefore it is theoretically 
impossible for a fetal specific immune response to occur within the intervillous space (see 
Figure 1.5). T cells could only mount an allo-reactive response if there is a breakdown of 
the syncytium during growth and shedding of the trophoblast layers, therefore providing 
access to fetal structures within the villi (potentially in the case of V.U.E). Indeed T cells 
found in the intervillous space may provide a protective role against bacterial infections of 
the placenta, rather than being a source for an anti-fetal response. Solders et al. (2017) 
demonstrated that human placental intervillous blood has an enriched population of MAIT 
T cells, a subset of T cell that recognizes microbial derived vitamin B metabolites, providing 
potential antimicrobial responses.  
 Despite the lack of MHC class I on syncytium, it is well documented that 
immunological changes occurring at the maternal-fetal interface is initiated with an 
inflammatory environment which is thought to allow for implantation (Dimitriadis et al. 
2005). This process is followed by progression towards an anti-inflammatory profile 
followed by a switch towards an  inflammatory environment again in order to facilitate 
parturition (Christiaens et al. 2008).  
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The earliest stage at which the maternal immune system is potentially primed for 
fetal tolerance is by the exposure to paternal semen. In the female reproductive tract, 
seminal plasma ellicit an inflammatory response and secretion of regulatory cytokine from 
cervical cells (Sharkey et al. 2007). The first critical step in successful pregnancy is 
implantation which requires constant communication between the embryo and the 
endometrium. During implantation there is an excess of cytokines, growth factors and 
hormones released from both fetal cells and maternal cells to initiate comprehensive 
implantation and decidualisation (Norwitz et al. 2001). Extravillous trophoblast facilitate 
the development of the decidua, and do express MHC Class I HLA-C, G and E. If an adaptive 
immune response was to develop at the maternal-fetal interface it would be based on this 
interaction with the extravillous trophoblast (Figure 1.5). Indeed the relative number of  
immune cell subsets in the decidua changes over time of gestation to allow for 
implantation, decidualisation and growth of the placenta. At the beginning of pregnancy 
the decidua is predominantly populated by uterine NK cells which interact with HLA-C and 
is critical for comprehensive implantation and decidualisation.  As gestation progresses the 
NK cells populations decrease and at term the decidua has subsets of macrophages, T cells 
and granulocytes (Gomez-Lopez et al. 2010). The original dogma for fetal tolerance during 
pregnancy was the general hypothesis of Th1 and Th2 balance. During pregnancy it was 
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thought that there was a shift to a more modulatory Th2 environment from a Th1 
response (Wegmann et al. 1993). However, this does not fully explain the complexity of 
maternal fetal immune interaction. Indeed, studies in mice have shown IL-4 null mutations 
have normal pregnancies (Svensson et al. 2001). In addition, Th1 associated cytokines are 
important in implantation, therefore the phenomenon of fetal tolerance during pregnancy 
is more complex than a shift from one cytokine environment to another (Trowsdale & Betz 
2006). As with intervillous T cells, the importance of the decidual T cells is not fully 
understood, and a shift towards Th2 cytokine anti-inflammatory profile might be a result of 
tissue repair environment that adapts to the growing placenta rather than to specifically 
limit a Th1 type anti-fetal tissue response.  
  
1.8. Peripheral immune changes  
 
Maternal peripheral changes of the immune system during pregnancy deviate towards a 
more tolerogenic state. Whether the peripheral change is a result of localised change at 
the decidua or whether peripheral immune tolerance in itself is an adaptive response is 
not yet fully understood. 
Murine studies have demonstrated that female pregnant mice accept engraftment 
of paternal allogeneic tumor tissue during pregnancy more readily than non-pregnant mice 
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(Adams et al. 2007). Immune communication via cytokines and chemokines play an 
important role in fetal tolerance, both systemically and locally (Robertson et al. 2011). It is 
also known that elevated levels of hormones, including progesterone, play an important 
role in maintenance of pregnancy. Progesterone induces progesterone-induced blocking 
factor (PIBF) which is expressed by T cells and has been shown to inhibit NK and Th2 
activation in mice (Blois et al. 2004).  
The main hypothesis of CD4+ T cells and their role in maintenance in pregnancy is 
that there is an establishment of a Th2 bias and a down-regulated Th1 response 
(Wegmann et al. 1993). It has been shown in murine models that TNF-α and IFN-γ can 
induce miscarriage; however, this can be ameliorated with the administering of Th2 
secreted cytokine IL-10, which has an anti-inflammatory effect (Chaouat et al. 1995).  
T regulatory cells are of great importance for normal pregnancy and fetal tolerance. 
Studies in mice have shown that deletion of T regulatory cells cause low implantation rates 
and high fetal reabsorptions (Shima et al. 2010). 
In humans it is well documented during pregnancy autoimmune conditions, such as 
rheumatoid arthritis where Th1 has a role in the pathophysiology of the condition, improve 
during pregnancy (Østensen & Villiger 2002; de Man et al. 2008), whilst conditions such as 
systemic lupus erythematosus, where a Th2 immune response is involved, increase in 
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severity.  Furthermore, a Th2:Th1 shift causes reduced cell-mediated responses, which is 
potentially responsible for increased susceptibility to influenza and leprosy where 
intracellular pathogenesis is primarily involved.  
 Leukocyte count is elevated during pregnancy and studies have shown there is 
innate activation (Sacks et al. 2003). Lissauer et al (2012) have also shown potential for 
adaptive immune responses towards male histocompatibility antigen, i.e.HY fetal antigens, 
during pregnancy. In pre-eclampsia the innate immune response is altered when compared 
to healthy pregnancy, which is related the systemic pathogenesis of pre-eclampsia (van 
Nieuwenhoven et al. 2008).  
 Several studies conducted on pregnant women verses non-pregnant controls have 
demonstrated an increase in IL-4 and IL-10 with a concurrent decrease in IFN-γ and IL-2 by 
ELISA and flow-cytometric experiments. This observation has been supported by analysis 
of mRNA levels where IL-4 mRNA has been shown to peak at month 7 with a decrease in 
levels of IFN-γ (Tranchot and Diallo et al. 1997). Th17 cells have a role in several 
autoimmune diseases and immune based disorders, and also in complications during 
pregnancy. It has been shown that there are higher levels of Th17 cells in preeclampsia and 
recurrent miscarriages compared to healthy pregnancies, and that this also coincides with 
a decrease in CD4+ T regulatory cells (Santner-Nanan et al. 2009; Lissauer et al. 2014).  
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In humans it has been shown that the peripheral levels of T regulatory cells are 
higher in pregnancy and that low numbers during gestation are associated with 
miscarriage and preeclampsia (Sasaki et al 2007).  
 
1.9. Decidual immune changes 
 
1.9.1. Decidual effector T cells 
 
Both murine and human studies have shown that T cells are critical for fetal tolerance, and 
reduced levels at the decidua can lead to pregnancy complications (Guerin et al. 2009). In 
humans, it has been shown that there are higher numbers of Th17 cells in the decidua of 
spontaneous abortion, however, the function of these subsets in tolerance at the maternal 
interface has not yet been elucidated (Wang et al 2010).  
At the human maternal interface, expression of IL-4, IL-10 and m-GSF  by T cells at 
the decidua is largely associated with successful pregnancy (Piccinni 2006). The localised 
tissue environment contributes to Th2 cytokine production, with IL-4, IL-6 IL-10 and IL-13 
being expressed by trophoblast tissue (Dealtry et al. 1998). Also, co-culture of T-cells with 
trophoblast cells results in an increase of Th2 regulatory transcription factors  GATA-3 and 
STAT-6, along with a reduction of Th1 STAT-4 regulatory transcription factor (Liu et al. 
2011). The anti-inflammatory effects of IL-4 and IL-10 results in an inhibition of Th1 cells 
25 
  
and macrophages, as well as inhibition of inflammatory cytokines such as TNF-α. This 
allows for cellular tolerance of the fetal-allograft. Despite this anti-inflammatory 
environment, Tilburgs et al (2010) demonstrated that in human decidual tissue, there are 
significant populations of differentiated effector memory CD8+ T cells, however their 
specificity was not identified.  
During labour, there is a shift from the immune tolerance equilibrium to a Th1 
inflammatory response at the maternal-fetal interface, which allows parturition. 
Progesterone is an important hormone for maintenance of pregnancy and is at a high level 
throughout pregnancy. However, at parturition, progesterone and IL-10 levels being to 
decline steeply, which, in turn, allows for an inflammatory response to occur (Zakar & 
Hertelendy 2007). At the decidua, amnion and chorion site there is an increase in IL-8, MIP-
1α MIP-1β and G-CSF and TNFα during parturition, all of which would be detrimental 
during the maintenance of pregnancy. These cytokines are associated with macrophages 
and neutrophils, which are involved in tissue degradation and phagocytic cell death. 
Interestingly, these cytokines are also detectable in cases of preterm labour, indicating a 





1.9.2. Decidual T regulatory cells 
 
CD4+ T regulatory cells  are deemed to play a critical role in immune modulation at the 
maternal-fetal interface (Aluvihare et al. 2004a). Murine studies have demonstrated that    
recruitment of T regulatory cells depends on the time of intercourse in respect to the 
menstrual cycle as well as hormonal levels (Robertson et al. 2013).  
Induced CD4+ T regulatory cells are generated upon stimulation of high affinity 
cognate TCRs by TGFβ and retinoic acid (Chen et al. 2003).  These are distinct from thymic 
T regulatory cells, where it has been observed that specific induction of enhancer of Foxp3, 
CNS1 and retinoic acid receptor binding sites facilitate Foxp3 and differentiation in 
peripheral T regulatory cells (Zheng et al. 2010). It has been demonstrated that blocking 
CNS1 in a mouse model abrogates peripheral T regulatory cells but not thymic T regulatory 
cells, and induces abortion of allogeneic pregnancies (Robert M. Samstein et al. 2012). 
Despite the importance of peripheral T regulatory cells in the maintenance of pregnancy 
during gestation, it has been demonstrated that thymic T regulatory cells mediate the 
implantation of mice embryos (Chen et al. 2013). Therefore, it is suggested that both 
thymic and peripheral T regulatory cells play a dual role in establishment and maintenance 
of pregnancy.  
Regulatory T cell specificity in pregnancy has only been demonstrated in mouse 
models thus far, principally by Rowe et al. (2012). They were able to demonstrate that 
transgenic mice expressing a surrogate fetal antigen, were able to generate peptide 
specific T regulatory cells and, furthermore, accumulate these throughout gestation and 
post-partum.  These T regulatory cells were furthermore able to proliferate at an 
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accelerated rate upon subsequent pregnancies with the same partner (Rowe et al. 2012). 
However, it is not known whether these peptide specific T regulatory cells were generated 
within the decidua, or in the periphery via circulating shed trophoblast debris or exosomes. 
Human studies have shown that peripheral circulation and decidual levels of T 
regulatory cells peak midway through gestation (Somerset et al. 2004). Studies performed 
by Saito et al. (2005; 2007) demonstrated the presence of FOXP3 mRNA in endometrial 
biopsies during the menstrual cycle, and that these levels are decreased in patients with 
infertility complications. Additionally, it was found that T regulatory cells peak at the late 
follicular phase and that women with recurrent spontaneous abortions had reduced 
numbers of T regulatory cells. Furthermore, changes in T regulatory cell populations were 
not significant during the menstrual cycle. These lower levels of T regulatory cells were 
found to be similar to those of post-menopausal women, and their suppressive capacity 
was both reduced and deemed functionally inept at immune regulation.  
In the context of cytokine levels,  reduction in T regulatory cell numbers is not 
correlated with reduced levels of IL-6, IL-4, IL-10, TNFα IFN-γ or GM-CSF and, therefore, it is 
suggested that IL-27 plays a major role in regulation of T regulatory cells during gestation 
(Wang et al. 2013). In addition to hormonal changes and cytokines, placental trophoblast 
produce high levels of TGF-β, which is able to recruit and induce peripheral CD4+ T 
regulatory cells (Ramhorst et al. 2012). Tilburgs et al. (2009) also suggest that due to 
reduction of peripheral T regulatory cells in matched maternal PBMCs compared to an 
increase in term decidua, there is specific recruitment to this site.  
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Further evidence of the importance of T regulatory cells in maintenance of 
pregnancy is their significance in pre-eclampsia. Several studies have indicated that 
imbalance and reduction of T regulatory cell levels correlate with pre-eclampsia (Toldi et 
al. 2008; Hsu et al. 2012).  
   
1.9.3. Uterine NK cells 
 
Uterine NK (uNK) cells constitute 70% of lymphocytes at the maternal–fetal interface 
during early pregnancy and are deemed to be the most important cell for successful 
pregnancy. Their interaction with other decidual leukocytes points to key functional cross-
talk during gestation. They are phenotypically different from peripheral blood NK cells and 
have an important functional role in the maintenance of fetal tolerance and 
decidualisation. uNK cells are characterised as being CD56 high CD16 negative with a loss 
of cytotoxic ability (Moffett-King 2002). Despite being rich in granzyme and perforin, they 
are cytotoxically weak and do not kill trophoblast in vivo (Veljkovic Vujaklija et al. 2013). 
They produce VEGF, placental growth factor (P1FG) and angiopoietin-2 (ANG2), all of which 
are important for trophoblast invasion of uterine tissue and subsequent vascularisation (Li 
et al. 2001). Interestingly, IFN-γ, a cytokine associated with potential detrimental cytotoxic 
activity, is also produced by uNKs and is critical for spiral artery remodelling (Ashkar et al. 
2000). IFN-γ along with IL-10 are thought to be required for maintaining immune 
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equilibrium as well as remodelling of decidual arteries (Vigano 2001).  Indeed, studies have 
shown that mice deficient for NK cells have abnormal spiral artery modelling (Hofmann et 
al. 2014) and that in humans, pregnancy complications such as pre-eclampsia and fetal 
growth restriction are often associated with  poor spiral artery formation and shallow 
trophoblast invasion (Pijnenborg et al. 1998). Important receptor interaction for uNK cells 
is the interaction of killer-cell immunoglobulin-like receptors (KIR) and fetal HLA-C ligand. 
Expression of HLA-C stops missing self activation of NK cells and it has been shown that 
non-compatible KIR and fetal HLA-C have  an adverse effect on pregnancy (Rodrigues et al. 
2013).  This crucial allo-recognition of trophoblast HLA-C and G elicits decidual angiogenic 
cross talk. 
 
1.9.4. Uterine Dendritic cells 
 
Along with uNKs, uterine dendritic cells are integral during early pregnancy and 
angiogenesis (Pollard 2008). In mice, when DCs are exposed to seminal and fetal antigens 
they elicit migration of other immune cells to the mucosa (Blois et al. 2014). uDCs are 
potent antigen presenting cells, that interact with trophoblast cells and recognise allo-
antigens during implantation and decidualisation (Tagliani & Erlebacher 2011). Despite the  
potential of initiating  an allogeneic response, in murine models it is suggested that the 
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decidua itself “entraps” uDCs, making them unable to traffic to lymphoid organs and 
thereby  limiting their antigen presenting capability (Collins et al. 2009a). Dendritic cells are 
skewed towards a tolerogenic function following secretion of granulocyte colony 
stimulating factor (GCSF) and granulocyte macrophage colony stimulating factor (GMCSF) 
by immune cells, and can recruit, generate and differentiate T regulatory cells via cytokine 
and IDO (Chen 2011). Depletion of dendritic cells and the maternal fetal interface in mice 
has shown to impair implantation (Plaks et al. 2008). It should be noted however than in 
human decidua, uterine dendritic cells are a very rare population, making up 1.7% of total 
CD45+ cells (Gardner & Moffett 2003) 
 
1.9.5. Decidual Macrophages  
 
 
Macrophages derive from myeloid progenitors found in bone marrow, which differentiate 
into promonocytes and then circulating monocytes. These cells next migrate 
transendothelially and differentiate into macrophages at tissue and organ sites which is 
where they play a crucial role in presentation of aberrant antigen peptide complexes to T 
cells. Upon fertilisation, macrophages traffic to the early decidua and are found to interact 
with trophoblast cells, which are partly responsible for macrophage chemotaxic signalling 
(Ivanisevic et al. 2010). Macrophages make up 10% of total leukocytes at the decidua, and 
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are seen to increase towards the end of gestation (Gomez-Lopez et al. 2010). Decidual 
macrophages in healthy pregnancy appear to exhibit an immunomodulatory and tissue 
remodelling role. Immunosuppressive molecules expressed by these “M2” type  
macrophages include IL-10, and IDO, an enzyme of tryptophan, which is crucial for T cell 
metabolism and function (Nagamatsu & Schust 2010). Indeed studies have shown that a 
reduced population of M2 macrophages at the decidua can influence pathologies of 
pregnancies, such as pre-eclampsia (Schonkeren et al. 2012).   















1.10. Fetal tissue adaptations 
 
In addition to maternal adaptions, fetal cells and tissue also have a direct role in immune 
tolerance during pregnancy. One of the most important aspects of fetal derived immune 
tolerance is the absence of expression of MHC class I molecules on villous cytotrophoblast 
and syncytiotrophoblast cells. Due to their absence, there is direct prevention of a class 
MHC class I presentation to T cells which, in turn,  prevents the recognition of allo-antigens 
(Munoz-Suano et al. 2011). However, HLA-C is expressed on distinct extravillous 
trophoblast which are responsible for invasion of the uterine wall, forming the decidua, 
and are essential to avoid non-self cytotoxic activation of NK cells and CD8 cytotoxic cells. 
HLA-G is also a MHC class I molecule expressed on extravillous trophoblast tissue, 
however, it is non-classical. HLA- G possess low polymorphism and can modulate allo-
reactivity by down-regulating CD8 and CD4 expression, thereby assisting in generation of T 
regulatory cells (Gregori et al. 2009).  T regulatory cells are able to secrete IL-10 and TGFβ 
that can supress cytolytic activity in a contact independent manner. Increased levels of 
soluble HLA-G has also been associated with increase in IL-10 and graft survival (Naji et al. 
2007). This suggests that HLA-G is able to promote tolerance locally at the placenta and 
also in the maternal peripheral immune system. HLA-G’s inhibitory receptors are found on 
NK cells, APCs, and T cells and consist of inhibitory receptor Ig-like 2 (ILT-2), ILT-4 and 
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KIR2Dl4. Interaction with these receptors grants protection from allogeneic responses 
from NK and cytotoxic T cells (Hunt et al. 2005).  
Trophoblast cells also express Fas ligands, which may bind to Fas receptors on T cells and 
induce T cell apoptosis. This mechanism has been shown to be important in modulating 
responses of CD8+ HY specific T cells in mouse models of pregnancy (Vacchio & Hodes 
2005).   IDO is also expressed by trophoblast cells. This reduces interaction of tryptophan 
with T cells which in turn inhibits T cell proliferation (Mellor & Munn 2004). In addition to 
apoptosis inducing Fas ligand, trophoblast cells also express tumor necrosis factor related 
apoptosis inducing ligand (TRAIL), which consequently induces apoptosis upon binding 
(Phillips et al. 2001). 
Figure 1.6 illustrates mechanisms and contributing factors from the decidual cells and 









































































































































































































































































































































































































































































1.11. T cells and responses to fetal antigen  
 
 
Allo-reactive responses against fetal tissue can be conducted towards mismatched non-self 
MHC  or minor histocompatibility antigens (mHAgs) (Tafuri et al. 1995; Goulmy 2006). 
Whereas MHC are involved in the introduction of peptides to immune cells, mHAgs are 
proteins that often present with different alleles between individuals due to deletions, 
single nucleotide polymorphisms (SNP) and/or the antigen being present on the Y 
chromosome, and can initialise an immune response (den Haan et al. 1998).  
mHAgs are presented to CD4+ and CD8+ T cells via MHC class I and class II 
molecules as previously discussed in section 1.2. It is important to point out at this stage 
that due to cross-presentation by DCs, CD8+, as well as CD4+ cells, can be  activated 
toward exogenous derived antigens provided by fetal matter despite the lack of MHC class 
I expression on trophoblast cells (Moldenhauer et al. 2009). Indeed, it has been shown that 
placental debris in the maternal immune system can be processed by DCs, presented to 
CD8+ T cells, which subsequently instigates an immune response in the maternal 
peripheral blood (Erlebacher et al. 2007). However, only HLA-C restricted antigen specific T 
cells would be able to carry out an allo-reactive response to placental tissue if trafficked to 
the decidua. Additionally, as syncytium of floating villi do not express MHC Class I, fetal 
specific T cells trafficked to the intervillous space would be unable to elicit an immune 
response (See figure 1.5) 
The role of mHAgs mismatch and the concurrent immune response was first 
demonstrated in transplantation studies. The cells were initially discovered for their role in 
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modulating graft versus host disease in bone marrow transplantation therapy.  Goulmy et 
al. (1976) showed how a HLA matched transplant was rejected in a male donor to female 
recipient transplantation.  It was shown that the female T cells could lyse HLA matched 
male donor cells, thus indicating a mHAg on the Y chromosome (Goulmy et al. 1977). 
Additionally, mHAgs were shown to elicit graft versus host disease, where donor female 
cells were able to lyse male recipient cells (Goulmy et al. 1983). These findings influenced 
the hypothesis that mHAgs may play a role in the outcome of pregnancy. In further 
support of the hypothesis one observation includes the instance where females with 
previous male pregnancies elicit graft versus host disease in transplant recipients, which 
was potentially due to maternal memory immune response to HY mHAgs, (Flowers et al. 
1990). Holland et al (2012) have shown several fetal mHAgs are expressed in human cord 
blood and trophoblast cells, including HY proteins RPS4Y1, DDX3Y and KDM5D (Holland et 
al. 2012).  In addition, murine studies  (James et al. 2003) have shown that maternal CD4+ 
and CD8+ T cells are able to elicit responses to endogenous HY antigen.  Given the 
proximity of maternal blood to syncytiotrophoblast cells throughout pregnancy, this 
provides a substantial source of potential activation. However, previously discussed 
mechanisms such as T regulatory cells, T cell deactivation, MHC class I and II restriction on 
trophoblast, and limitation of maternal dendritic cells to migrate from the pregnant uterus 
to conduct antigen presentation (Collins et al. 2009a), suggest why fetal-specific responses 
are not generated to cause widespread fetal rejection (Kahn & Baltimore 2010; Nancy et al. 
2012). 
  Despite this, fetal microchimerism provides an alternative source for allo-reactivity 
towards fetal antigens. Fetal microchimerism describes fetal cells that are trafficked to the 
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maternal peripheral blood supply, which in turn, provide a source of fetal mHAgs to the 
peripheral immune system (Evans et al. 1999).  Syncytiotrophoblast is constantly shed 
during pregnancy where there is renewal of cytotrophoblast forming the placental villi. 
Studies have shown that up to 1g per day of this tissue is shed from a term placenta, and 
therefore provides an additional supply of fetal mHAgs (Burton & Jones 2009). Studies in 
humans have shown that following   pregnancy   there is a generation of responses to 
mHAgs which persist for long periods of time post-pregnancy, (Verdijk et al. 2004). More 
recently, Lissauer et al (2012), demonstrated that CD8+ T cells specific to paternal HY 
antigens were present during pregnancy in maternal peripheral blood in pregnancies with 
a male fetus, and that these cells were capable of producing IFN-y (Lissauer et al. 2012). 
The epitope that was detected in this case was derived from the HY protein KDM5D. The 
fetal antigens are assumed to be cross-presented by maternal, or even potentially by fetal 
microchimeric antigen presenting cells, such as monocytes and macrophages (Seavey & 
Mosmann 2006; Moldenhauer et al. 2010; Moldenhauer et al. 2009; Erlebacher et al. 
2007). Additionally, scavenging DCs can phagocytose fetal antigen in the periphery, and 
traffic to lymph nodes where the antigen is presented (Taglauer et al. 2010). It is therefore 
possible that an allo-reactive fetal specific response is generated away from the 
immunodulatory environment of the decidua.  
   The role of fetal mHAg and its clinical impact on immune dysregulation 
during pregnancy is deemed to be highly correlated. One example is that placentas in pre-
eclamptic pregnancies show upregulation of minor histocompatibility antigen HA-1. It has 
been suggested that this introduces an additional load of antigenic immune response and 
contributes to an overall immune imbalance involving increased proinflammatory effects 
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which are characteristic of pre-eclampsia (Kronborg et al. 2011). mHAgs have also been 
suggested to play a role in recurrent miscarriage. Epidemiologically it has been shown that 
the likelihood of secondary miscarriage is increased if the first pregnancy was male (Ooi et 
al. 2011). Additionally, women that have had secondary recurrent miscarriage possess 
upregulated MHC class II molecules capable of presenting HY mHAgs (Christiansen et al. 
2010). This suggests that recurrent miscarriage can be linked to the generation of Y-
chromosome linked T cell memory during the first pregnancy, which later affects the 
outcome of subsequent pregnancies resulting in a male fetus (Christiansen et al. 2011).   
Murine models of pregnancy have provided a greater understanding of the 
trafficking of fetal cells, immune function at the placenta and antigen specific allo-
reactivity. However, due to specific anatomical and immunological differences, such as 
murine trophoblast expressing MHC class I later in gestation (Jiang & Vacchio 1998), there 
is a limit to how much murine pregnancy immunology is translatable. For instance, murine 
studies have suggested that epigenetic silencing of key chemokines in the decidual stroma 
may limit T cell access to the decidua and thus their activation to allo-antigen is restricted 
(Nancy et al. 2012). However Villitis of Unknown Etiology, a condition characterised by a 
high CD8+ inflammatory T cell response, is relatively common, even in healthy pregnancy. 
Tilburgs et al (2010) have also demonstrated differentiated CD8+ T cells to be present in 
the human decidua. Importantly, despite examples of fetal specific T cells being detected 
in the human periphery, no studies, to date, have demonstrated fetal specific T cells in situ 
at the maternal-fetal interface. This project aim to address this, and suggest that despite 
evidence in murine models that fetal specific T cells are limited in their trafficking to the 




1.12. Co-stimulatory factors and immune checkpoint proteins in 
pregnancy  
 
For effective T cell activation to occur, two signals are required via APCs. Firstly, there is 
the antigen specific interaction of the TCR and the MHC-peptide complex. Secondly, an 
antigen independent co-stimulatory signal is required, which involves specific ligands 
expressed by APC, interacting with their cognate receptors on T cells. In the absence of co-
stimulatory interaction, T cells can enter a state of anergy or apoptosis (Mueller et al. 
1989). Co-stimulatory signalling pathways can be both positive in that they promote T cell 
activation or negative, where T cell responses are mediated and tempered. Studies have 
shown that certain negative co-stimulatory interactions play a role in the maintenance of 
pregnancy.  Figure 1.7 summarises the negative co-stimulatory molecules and their 
cognate ligand discussed in the following sections. Negative co-stimulatory molecules can 
also be referred to as immune checkpoint proteins or exhaustion markers. For simplicity, 
these molecules will be collectively referred to as immune checkpoint proteins throughout 




Programmed death-1 receptor (PD-1) and its ligands PD-L1 and PD-L2 are one such co-
stimulatory pathway, which has been demonstrated to deliver inhibitory signals and 
balance T cell activation (Sharpe et al. 2007). Binding of PD-1 to its ligand enacts a state of 
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“exhaustion” of  T cells in tumour microenvironments (Driessens et al. 2009) and it is seen 
to elicit a similar suppressive environment at the maternal-fetal interface.  
 Despite being also expressed during thymic development, PD-1 is expressed 
classically upon cell activation and has been found to be present on DCs, monocytes, and B 
cells, as well as T cells (Keir et al. 2008). Additionally, cytokines IL-2, IL-17 and IL-15 have 
been found to induce PD-1 expression (Kinter et al. 2008).  PD-L1 is expressed on a broad 
range of haematopoietic cells as well as non-haematopoietic cells and tissues, including 
epithelial cells and the placenta. PD-L1 expression can be upregulated in the presence of 
inflammatory cytokines such as IFN-γ, TNFα and can therefore establish an activation-
mediation feedback loop.  
 Standard T cell activation involves TCR signalling and CD3/CD28 co-stimulation, 
which in turn activates phophoinosotide 3-kinase (PI3K) followed by protein kinase B (AKT). 
Whilst this pathway elicits cytokine secretion and T cell proliferation, PD-1 inhibits PI3K 
and the downstream AKT activation. Also PD-1 reduces zeta-chain associated protein 
kinase (ZAP)-70 expression and inhibits protein kinase θ phosphorylation and extracellular 
signal regulated kinase (Erk) activation. This results in reduced cytokine production, 
proliferation and survival signalling (Zhang et al. 2004; Parry et al. 2005; Gianchecchi et al. 
2013). In addition to modulating effector T cell activation, PD-1 signalling is critical for the 
development of T regulatory cells. Studies involving blocking of PDL-1 on APCs results in 
minimal development of T regulatory cells, and instead can cause an increase in Th17 cells 
in pregnant mice, which affects maternal-fetal tolerance (Francisco et al. 2009; D’Addio et 
al. 2011). As both APCs and T regulatory cells can present PD-L1 in the decidua, the 
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combination of these inhibitory signals is crucial for reducing the magnitude of T cell allo-
reactive responses. Decidual stromal cells constitutively express PD-L1 and their contact 
with decidual T cells is suggested to be a crucial in modulating T cell activation at this site. 
Indeed, blocking PD-L1 on decidual stromal cells resulted in an increase of CD4+ cytokine 
production in vitro. In addition to stromal decidual cells, PD-L1 is expressed on  
cytotrophoblast, and even more so on syncytiotrophobalst from the second trimester 
(Holets et al. 2006). However, their interaction with T cells may be inhibited due to MHC 
molecule down-regulation on trophoblast. Extra-villous trophoblast, and more specifically 
invading cytotrophoblast cells in the decidua, express HLA-C and HLA-G and a potential 
suppressive signalling pathway with decidual T cells is therefore possible. Macrophages 
make up 20 to 30% of total leukocytes in decidual tissue and only decrease at term. 
Despite specific immunomodulatory mechanism not being characterised between decidual 
T cells and macrophages, studies have shown that they can supress IFNγ secretion via PD-
L1 and PD-1 interaction (Sayama et al. 2013).  
As previously discussed in section 1.10, the Th2:Th1 skew at the maternal-fetal 
interface is seen as a crucial mechanism of fetal tolerance, in which PD-1 pathways may be 
involved. Several studies have demonstrated that blockade of PD-L1 in mice can lead to 
abortion, fetal reabsorption, and increase in Th17 proportion (Guleria et al. 2005; D’Addio 
et al. 2011). T regulatory cells constitutively express PD-L1, indicating that this co-
stimulatory pathway is central to mediating Th1, Th2 and Th17 balance at the maternal-
fetal interface. In humans, PD-1 expression on T cells is elevated in healthy pregnancy 
(Grozdics et al. 2014) and an increase in Th17, along with a decrease in T regulatory cells 
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(Darmochwal-Kolarz et al. 2013), suggests that PD-1 co-stimulatory pathways are crucial 




T cell immunoglobulin domain and mucin domain 3 (Tim-3) is another co-stimulatory 
marker that has a suppressive or inhibitory effect on T cell activation. Its ligand is Galectin-
9 (Gal-9), which engages downstream apoptotic signalling (Zhu et al. 2005). Tim-3 was 
originally identified on Th1 cells and was later found to be important in Th17 and CD8+ T 
cell modulation, where blockade of Tim-3 in mouse models resulted in an increased 
autoimmune responses (Sánchez-Fueyo et al. 2003). As with PD-1, Tim-3 has more recently  
been regarded as a crucial marker for tumour associated immune suppression (Sakuishi et 
al. 2011) and modulation of pregnancy (Li et al. 2014).  
 Gal-9 is expressed by T cells, B cells and macrophages as well as endometrial tissue 
during the decidual phase of gestation (Shimizu et al. 2008) and is regulated by the 
expression of IFN-γ. A feedback loop is initiated in an inflammatory environment, where 
Gal-9 expression is induced in T cells, B cells and macrophages, which leads to increased 
interaction with Tim-3 on Th1 cells, the major IFNγ producers, and subsequent apoptosis is 
induced. Furthermore, CD8+ T cells that express Tim-3 have shown reduced ability to clear 
virus and tumour cells (Fourcade et al. 2010). However, decidual CD8+ T cells that are Tim-
3+ do not show a classical exhausted phenotype. Instead, they exhibit increased 
proliferative capacity along with secretion of anti-inflammatory cytokines (Meggyes et al. 
2014). Subsequent studies in mice demonstrated that blockade of Tim-3 resulted in 
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decreased proliferation of decidual CD8+ T cells and a shift to IFN-γ secretion, which 
resulted in increased fetal loss (Wang et al. 2015). In addition, CD4+ T regulatory that 
express Gal-9, have been shown to have increased suppressive function (Wu et al. 2014). 
Although Tim-3+ T regulatory cells at the maternal-fetal interface have not been reported 
in the literature, one would suggest that Tim-3 Gal-9 signalling pathways play an important 
part in the this system, given the importance of T regulatory cells in the modulation of 




Another significant negative costimulatory molecule involved in mediating T cell responses 
is cytotoxic T-lymphocyte antigen-4 (CTLA-4). T cell activation often involves the binding of 
CD28 to CD80/86 molecules presented on antigen presenting cells. However, if CTLA-4 
bind CD80/86 in this co-stimulatory signal pathway an inhibitory response is enacted 
(Boussiotis et al. 1996). Blocking of CD80/86 has led to long term allograft acceptance and 
also successful embryo implantation in abortion prone murine models (Jin et al. 2005). 
CTLA-4 was found to be significantly reduced in human decidual T cells in cases of 
miscarriage compared to normal pregnancy (Jin et al. 2009). In addition, the expression of 
CTLA-4 was also negatively correlated with IL-2 and IFNγ cytokine production. Human 
studies have also demonstrated that CTLA-4 is expressed on T regulatory cells stimulated 
by trophoblast (Svensson-Arvelund, Ratnesh B Mehta, et al. 2015). Despite the lack of 
direct studies into CTLA-4 and its function in modulation of pregnancy, it has been 
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suggested that that it is another important costimulatory marker in regulating 




Lymphocyte activation gene-3 (Lag-3) is upregulated on activated CD4+ and CD8+ T cells 
and some NK cells (Triebel et al. 1990). Lag-3 is structurally similar to the CD4 co-stimulator 
receptor, and competes with this molecule for MHC class II binding. As CD8+ T cells do not 
interact with MHC class II it is thought that Lag-3 binds to alternative ligands on these cells, 
such as liver sinusoidal endothelial cell lectin (LSECtin) expressed on tumour cells (Xu et al. 
2014). Lag-3’s significance in modulating immune responses has been demonstrated in 
murine models. Here data show that Lag-3 deficient mice are unable to control T cell 
expansion following allo-antigen activation (Huang et al. 2004). In addition to effector T 
cells, T regulatory cells also express Lag-3, and it has been demonstrated that blockade of 
Lag-3  on these cells abrogates their suppressive function (Huang et al. 2004). As with 
CTLA-4 there is a lack of literature that directly address Lag-3 expression in maintenance of 
pregnancy, however, its role in tumour suppressive environments,  expression on T cells to 
control unmitigated expansion and T regulatory cell function suggest that it may play an 












Effector T cells upregulate immune checkpoint proteins as PD-1, Tim-3, 
Lag-3 and CTLA-4 on their surface. Ligation of these receptors with PD-
L1, Gal9, MHC class II molecules and CD80 or CD86, respectively, 
delivers inhibitory signals to the effector T cells and controls their 
inflammatory activity. (Rouse & Sehrawat 2010).  
 
Figure 1. 8 Summary of inhibitory receptors and 




1.13. T cells and Pathologies of Pregnancy 
 
There are many pathologies that affect the outcome of pregnancy involving various 
bacterial and viral infections and autoimmune diseases. However, for brevity I shall 
address pathologies that are most commonly associated with an immunological phenotype 
associated with the breakdown of immune modulation towards the placenta.  
1.13.1. Pre-eclampsia and spontaneous abortion. 
 
Pre-eclampsia is a syndrome which is often associated with first time pregnancies, but it 
can also occur in subsequent pregnancies. The condition is associated with high blood 
pressure, protein in the urine (proteinuria) and edema (Zhou et al. 2002). However, what 
clearly defines the onset of pre-eclampsia is the ineffective vascularisation of the maternal-
fetal interface, which is why pre-eclampsia is also often associated with intrauterine 
growth restriction (Redman & Sargent 2005).  The trophoblast cells identified in patients 
suffering pre-eclampisa, are characterised by their inability to express adhesion receptors 
that are needed for invasion of the uterine wall (Damsky & Fisher 1998). Invasion of the 
uterine wall is therefore shallow and spiral artery remodelling is incomplete. This results, 
ultimately, in less maternal blood bathing the placental villi and reduced gaseous and 
nutrient exchange.  
 One cell type that may be a crucial factor in preventing pre-eclampsia is T 
regulatory cells. Several studies have suggested that a reduced number of peripheral blood 
and decidual T regulatory cells are associated with pre-eclampsia and spontaneous 
abortion (Toldi et al. 2012; Sasaki et al. 2007; Wang et al. 2010). As a result of T regulatory 
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cell immunosuppressive capacity, involving expression of IL-10 and TGF-β these cells have 
been seen to limit effector T cell activity over the course of pregnancy, where more and 
more allo-antigen ultimately will be processed and presented. Without this limiting effect, 
Th1 and Th17 cells would induce detrimental cytotoxic responses effecting spiral artery 
remodelling. Indeed studies observed a correlation between an increased in Th17 cell 
frequencies with pathogenesis of spontaneous abortion (Wang et al 2010).  
1.13.2. Villitis of Unknown Etiology 
 
Villitis of Unknown Etiology (V.U.E.) is an inflammatory lesion of the placental villi, with an 
absence of any bacterial or viral source of inflammation (Kim et al. 2008). It is the most 
common of placental lesions, occurring in up to 15% of term pregnancies and is usually 
visualised during routine diagnostic histology with a higher incidence during 3rd trimester 
of gestation (Redline 2007). V.U.E is defined histologically by large T cell infiltrate, 
predominately CD8+, along with fetal derived Hofbauer macrophages (Kim et al 2008). 
V.U.E. was first recognised in the 1960’s; however, it was only identified as not having an 
infective etiology in 1975 (Altshuler et al. 1975), and to this day, the exact inflammatory 
factor has not yet been discovered.  
 V.U.E is only diagnosed following histopathological analysis and exists in many 
variants depending on the pattern of inflamed trophoblast. Classically V.U.E. is 
characterised by inflammatory cell infiltrate of the placental villi, often incurring disruption 
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and destruction of the vascular structure and widespread deposition of fibrin at areas of 
necrosis. It differs from bacterial or viral villitis as it has a non-uniform inflammation of villi, 
with areas completely unaffected and maintaining normal histological architecture 
(Redline 2007). In addition, V.U.E commonly affects only the distal placental villi; however, 
less commonly it can also affect the chorionic plate and stem villi. As a result of infiltrating  
lymphocytes, macrophages, and  granular cells there is often potential for obliterative fetal 
vascularopathy which has significant complications in pregnancy (Boog 2008). It is often 
described as occurring in up to 15% of term placenta, however, the reported range varies 
between 2% and 33.8% (Labarrere et al. 2005).  
 Cellular composition of V.U.E is described as predominantly maternal derived T cell 
lymphocytes (42%) with a higher proportion of CD8+, macrophages (54%) of both maternal 
and fetal origin, along with small numbers of B-cells (2%) (Kapur et al. 2004). Interestingly, 
despite a strong association of T regulatory cells in the maintenance and immunotolerance 
of the fetus, it has been shown that T regulatory  cells are increased in V.U.E compared to 
normal placentas (Katzman et al. 2011).  
 Even though V.U.E. is relatively common occurrence in normal placentas the 
syndrome is associated with adverse pregnancy outcomes, including intrauterine growth 
restriction (IUGR) and small for gestational age (SGA) (Becroft et al. 2005), neurological 
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impairment (Redline et al. 2000), and still birth and perinatal mortality (Redline & 
Abramowsky 1985). As well as diagnosis of V.U.E it’s severity, i.e. high grade and diffuse is 
also associated with adverse pregnancy outcome. More severe V.U.E is likely to reoccur 
during subsequent pregnancies with increased adverse effects and risk of intrauterine 
death (Redline et al 2000). 
 Despite peripheral, decidual and fetal mechanisms of maternal-fetal tolerance 
during pregnancy, it is widely considered that V.U.E is a form of allograft rejection, where 
the maternal–fetal tolerance has degraded to a level where there is significant cytotoxic 
lymphocyte recruitment and infiltrate (Taglauer et al. 2010). Indeed, it has been shown 
that women with autoimmune diseases, where there is already a breakdown of systemic 
and localised immunotolerance, there is an increased incidence of V.U.E. (Labarrere et al. 
1986). Even though there is still no clear etiology of V.U.E., we can compile evidence from 
numerous studies of the immunology of the maternal-fetal interface to construct potential 
pathways for V.U.E to develop out of a number of immune abnormalities.  
Whilst the antigenic etiology of V.U.E has not yet been defined, it is widely assumed 
that it is of fetal origin. Indeed, it has been shown that in peripheral blood, a maternal 
CD8+ T cell immune response to HY fetal antigens can be detected. These fetal specific T 
cells increase as pregnancy progress and have been shown to have functional ability and 
50 
  
cytotoxicity (Lissauer et al. 2012). A separate study has also shown that these fetal specific 
T cells persist following pregnancy for many years and increase following subsequent 
pregnancies (Piper et al.  2007). Due to V.U.E being characterised as a lesion comprising of 
predominately a CD8+ T cell infiltrate, it can be hypothesised that the maternal immune 
system is primed substantially to fetal antigens and that these traffic to maternal-fetal 
interface.  
 As previously mentioned, tolerance from the maternal immune system is required 
for a successful pregnancy, and of particular importance are T regulatory cells. This has 
been shown in both mouse models, where the absence of the T regulatory cells results in 
loss of pregnancy and in human tissue studies, where the cells have a predominant role in 
maternal allo-reactive response to fetal antigen modulation (Tilburgs et al. 2008a). Having 
said this, it has been shown that the numbers of T regulatory cells in V.U.E. tissue was 
comparatively higher than that of controls (Katzman et al. 2011). Whether these have a 
direct role in progression of V.U.E. or that they accumulate in response to a high 
inflammatory response in V.U.E. has not been studied.  
During pregnancy the cytokine environment is skewed towards a Th2 profile of IL-4, 
IL-5 and IL-10. This in turn limits pro inflammatory Th1 associated cytokines IFNγ and TNFα 
and the cytotoxic potential of CD8+ T cells and macrophages (Walker & Abbas 2002). 
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However, studies have shown that both Th1 or Th2 dominant profiles have a detrimental 
effect on the outcome of pregnancy (Saito et al. 2010). This implies that the assumption 
that Th1 increases risk of V.U.E. whilst Th2 decreases cytotoxicty is unreliable, and that a 
more complex cytokine environment may play a part, involving Th17 cells, T regulatory 
cells and fetal and maternal derived macrophages. T regulatory cells can be generated by 
tolerogenic antigen presentation cells in presence of a diverse range of factors including IL-
10, TGFβ  GM-CSF and IL-4. In addition, Th17 cells and IL-17 are  involved in autoimmunity 
and inflammation, and may therefore also have a role in V.U.E. Disruption of these 
cytokine environments may induce multiple pathways leading to loss of tolerance and an 
increased likelihood of cytotoxic activation, proliferation and infiltration (Guerin et al. 
2009).  
 In addition to the role of inflammatory and tolerogenic cytokines involved in V.U.E., 
chemokines and cell trafficking are also of particular interest. Immunohistochemistry has 
demonstrated that the lymphocytes present in V.U.E. affected villi are of both maternal 
and fetal origin (Myerson et al. 2006) . Subsequently, unless there is significant 
homeostatic proliferation of activated T cells, there must be important roles for chemokine 
associated trafficking to inflammatory sites. Kim et al. (2009) performed microarray 
analysis of human derived V.U.E. tissue and normal placental tissue and were able to 
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demonstrate Th1 chemokines CXCL9 and CXCL10 were upregulated in V.U.E, as well as 
their receptor CXCR3 (Kim et al. 2009). Conversely, a separate study demonstrated that in 
normal decidual tissue there is epigenetic silencing in decidual cells of CXCL9, CXCL10, and 
it is hypothesised that T cell trafficking to the decidua is limited (Nancy et al. 2012). This 
might  be purported as another mechanism of immunotolerance at the maternal-fetal 
interface. However, this analysis was carried out on a small sample size of mice and may 
therefore not reflect accurately chemotaxis in human placenta. 
 Infiltration through the trophoblast layer to the villous stroma is decreased  by 
reduced expression of intercellular adhesion molecule 1 (ICAM-1) (Petroff 2005). However, 
it has been shown that in V.U.E., ICAM-1 expression is increased and TNFα and IFNγ have 
been shown to upregulate ICAM-1 on trophoblast. Therefore, it is suggested that a pro-
inflammatory environment upregulates expression of ICAM-1 and intravillous invasion of 
lymphocytes in V.U.E. (Labarrere et al. 2005).  
It has been suggested that V.U.E. is a form of semi-allograft rejection, where 






1.14. Flow cytometric analysis of T cells 
 
Flow cytometry is a widely used technique in the study of leukocytes, as well as other cells. 
It allows the quantification and assessment of size, granularity and cell surface or 
intracellular peptide expression. Through the use of fluorochrome conjugated monoclonal 
antibodies binding to specific peptides, cells pass through a high-speed fluidic system, and 
different lasers (often 405nm, 488nm and 635nm) excite the fluorochomes conjugated to 
cells. Light emission is then detected by photomultiplier tubes and “events” corresponding 
to individual cells are recorded and presented using various software programs. Size and 
granularity of cells are determined by diffracted (forward scatter) and refracted (side 
scatter) light respectively, whilst markers such as CD3 or CD4 are detected using antibody-
conjugated fluorochromes. Some of the first analyses of decidual T cell using flow 
cytometric techniques were performed by Starkey et al. (1988) and Watanabe (1987), who 
were able to describe CD2+ and CD3+ populations.  
 For detection of antigen specific T cells, MHC-peptide complexes are used to detect 
specific T cell receptors. Due to TCRs having low affinity to MHC-peptide complexes, it can 
be difficult to detect or distinguish between similar specificities by using monomer based 
complexes. This is why multimers are now often used for antigen specific TCR detection. By 
having multiple MHC-peptide complexes able to bind the TCR at multiple sites on one cell, 
the technique allows for increased sensitivity and stability.  Recently, dextramers, which 
possess a dextran polymer backbone, have been developed. These are able to carry more 
MHC-peptide complexes and fluorochrome molecules, allowing for enhanced staining 
intensity and the detection of potential rare TCR specificities. Due to their high avidity, 
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background noise is reduced, which allows for a more confident assessment of 









1.15. Analysis of the cellular transcriptome 
 
Transcriptomics is the measurement of all the cell(s) gene transcripts, which includes non-
coding RNAs, mRNAs and small RNAs. This is, therefore, a highly sensitive measurement of 
the molecular mechanisms of cells at a transcriptional level in response to applied 
conditions, treatments and pathologies. To date, DNA microarrays and RNA sequencing are 
the two techniques commonly used for global transcriptome analysis (Fang et al. 2012).  
 DNA microarrays consist of highly densely packed oligonucleotide sequences 
coupled to precise locations on a chip. mRNAs are then allowed to hybridise to these 
probes and measurement of transcripts relative to a control transcriptome or differing 




Figure 1. 9 Schematic of dextramer 




cellular pathways are affected by measuring the relative increase or decrease of transcripts 
from a particular gene. cDNA microarrays consist of cloned probe molecules that 
correspond to well-characterised expressed sequences, whilst oligonucleotide microarrays 
utilize synthesised probes based on prior knowledge of specific transcripts (Murphy 2002; 
Maughan et al. 2001).  A typical microarray experiment is demonstrated in Figure 1.9. First, 
total RNA is isolated from the cell type in question and quantified. These mRNAs are then 
converted to cDNA in a reverse-transcriptase enzyme reaction. The library of cDNA 
afterwards is then labelled with fluorescent dye and then hybridised with target probes on 
the microarray chip. Following washing procedures, chips are scanned and fluorescence 
measured. Using specialist software, the transcriptome of each sample is outputted as a 
raw format, ready for normalisation procedures, bioinformatics and statistical analysis.  
 Koopman et al. (2003), was one of the first groups to utilise microarray analysis on 
decidual leukocytes, in this case NK cells. More recently, studies by Tilburgs et al. (2010) 
and Apps et al. (2011) have used microarray technology to study trophoblast tissue to 




















One-color expression analysis uses a single 
fluorescent label (green) and two microarray 
chips to generate transcriptome expression 
profiles for two or more cell samples. 
Upregulated and downregulated genes 
(green and red squares, respectively) are 
obtained by superimposing images obtained 







Figure 1. 10 Summary of procedures for 




1.16. Aims of project 
 
The aims of this project are: 
 
1) To fully characterise effector T cells at the maternal-fetal interface in healthy 
pregnancy: 
a. The phenotype and functionality of T cells at the maternal–fetal interface, 
i.e. the decidua basalis and decidua parietalis, trophoblast tissue, will be 
assessed and compared to matched maternal peripheral blood and cord 
blood. 
2) To elucidate mechanisms by which these T cells may be regulated during 
pregnancy: 
a. CD4+ T regulatory cell populations will be investigated, as well as inhibitory 
receptor expression on effector T cells.  
3) To assess the allo-reactivity of T cells at the maternal-fetal interface towards fetal 
antigen:  
a. Populations of HY specific decidual CD8+ T cells will be determined in 




b. Mixed lymphocyte reactions of decidual T cell and peripheral blood against 
matched cord blood leukocytes will determine intensity of allo-reactive 
response to fetal antigen, and how regulatory factors may inhibit this.   
4) To assess how potential transcriptional differences between decidual effector T 
cells and maternal peripheral blood T cells may play a role in maternal-fetal 
immune response.  
a. A microarray of decidual CD4+ and CD8+ effector memory T cells against 
matched maternal peripheral blood will be carried out and the analysis of 
these will assist in defining important immune pathways that may be 









2.1. Media and Solutions 
 
Wash media -  RPMI 1640 (Sigma, UK) 
100U/ml Penicillin (Gibco, UK)  
100 µg/ml Streptomycin (Gibco, UK)  
 
General media- RPMI 1640 (Sigma, UK)  
100U/ml Penicillin (Gibco, UK)  
100 µg/ml Streptomycin (Gibco, UK)  
2mM Glutamine (Gibco, UK)  
10% Fetal Calf Serum (SBS Biologicals, UK)  
 
Freezing media-  Fetal Calf Serum (SBS Biologicals UK)  
10% DMSO (Sigma, UK)  
 
MACS buffer-   1 x Phosphate Buffered Saline (PBS) (University of Birmingham)  
0.5% Bovine serum albumin (Sigma, UK)  
2mM EDTA (Sigma,UK)  
Sterile filtered  
TBE Buffer-   89nM Tris HCL 
89nM Boric Acid 
3mM EDTA  
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2.2. Mononuclear cell isolation from placental tissue and 
peripheral blood 
 
Placental tissue was obtained from healthy mothers undergoing 3rd trimester elective 
caesarean section. Peripheral blood and cord blood samples were also obtained at this 
time. Decidua basalis, decidua parietalis and trophoblast tissue was dissected. Sterile 
scalpel and tweezers were used on the main body of the placenta to cut away the top layer 
of decidua basalis from underlying trophoblast tissue. Figure 2.1 demonstrates the 
macroscopic areas of dissection. Additionally, the maternal side of the decidua parietalis 
was gently scraped with a scalpel and tissue was collected. All tissues were dissected and 
collected from multiple sites of the placenta. Each tissue sample was washed three times 
sterile PBS to remove contaminating blood. Decidua basalis, decidua parietalis and 
trophoblast were then dissociated via Miltenyi GentleMACs using program “Human 
Spleen” in 7.5mls of wash media using C-Tubes (Miltenyi, US). Samples were then 
enzymatically digested by adding 1mg/ml collagenase (Sigma, UK) and 200U/ml (Sigma, 
UK) and then placed on a rotator for 45 minutes at 37oC. Digested tissue was then filtered 
into new 50 ml tubes using Smart Strainers 50µm (Miltenyi, US) along with 30mls of sterile 
wash wash media. Samples were centrifuged at 300g for 10 minutes. Pellets were re-
suspended in wash media and were pipetted on to a density gradient medium Lymphoprep 
(Alere, NO) and centrifuged for 30 minutes at 758g without brake to isolate mononuclear 
cells. Maternal and cord blood mononuclear cells were also separated using the density 
gradient method. The layer suspended above the lymphoprep was pipetted into a new 50 
ml tube, and re-suspended in up to 50mls of wash media. Samples were centrifuged at 
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300g for 10 minutes. Supernatant was removed, and cells were re-suspended again in up 
to 50 mls of wash media and centrifuged at 300g for 10 minutes. Supernatent again was 
removed and then re-suspended in 20 mls of general media. An aliquot of each sample was 
pipetted on to a haemocytometer, and leukocytes per ml and total cells were counted. 
Separately, a full thickness section of the placenta was cut and fixed in 4% formalin and 
was subsequently paraffin embedded by the Birmingham Women’s Hospital Pathology 







Maternal- Fetal interface: 
Decidua 
Trophoblast  Decidua basalis 
Decidua Parietalis 
Decidua basalis and 
trophoblast tissue washed 
in PBS 
Figure 2. 1 Placental Tissue Dissection 
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2.3. Flow cytometry using LSRII 
 
 A general gating strategy using flow cytometry was used to identify CD4+ and CD8+ T cells 
throughout the study. Single cells were identified on a forward scatter area vs forward 
scatter height plot, and lymphocytes gated on the basis of standard forward and side 
scatter properties. A “dump” channel was used to exclude dead cells (using PI), monocytes 
(CD14) and B cells (CD19). T lymphocytes were then selected by CD3 expression. CD3+ T 
cells were then categorised again based on CD4+ and CD8+ expression (Figure 2.2) 







































2.4. Characterisation of T cells phenotype and functionality using 
flow cytometry 
 
To phenotype T cell memory status, 106 fresh maternal, cord blood, decidual or 
trophoblast mononuclear cells were centrifuged at 300g for 5 minutes in 5 mls of PBS, 
supernatant removed and re-suspended in 100ul of MACs buffer. Table 2.1 lists the 
antibodies used:  
Antibody Fluorophore Clone Company 
CD3 Amcyan SK7 Becton Dickinson UK 
CD4 PE RPA-T4 Cambridge Bioscience UK 
CD8 Efluor450 OKT8 eBiosciences UK 
CD45RA AF700 HI100 Biolegend UK 
CCR7 FITC 150503 Becton Dickinson UK 
CD27 APCeFluor 780 0323 eBiosciences UK 
CD28  PerCPCy5.5 L293 Becton Dickinson UK 
CD57  APC HCD57 Biolegend UK 
CD14 ECD RM052 Beckman Coulter UK 
CD19 ECD J3-119 Beckman Coulter UK 
Propidium 
Iodide 
ECD NA Becton Dickinson UK 
 
Samples were then analysed using LSRII (Becton Dickinson, UK).  
Table 2. 1 T Cell Memory Phenotype Antibodies 
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To phenotype intracellular cytokines and T regulatory cell status, prior to antibody 
staining, monocular cells were incubated in RPMI supplemented with L-glutamin (Sigma, 
UK), bovine foetal calf serum (Sigma, UK) with 50ng/ml of PMA (Sigma) and 1ug/ml of 
Ionomycin (Sigma, UK) for 4 hours. After 30 minutes, 1.25ug/ml of monencin was added. 
Unstimulated samples were set up in parallel. Samples were then prepared for surface 
antibody staining as previously described. Following surface stain incubation, samples 
were centrifuged at 300g for 5 minutes in 5 mls of PBS, supernatant removed and re-
suspended in 1ml/ 106 cells of  Fix/Perm solution (eBioscience, UK) for 30 minutes. Samples 
were centrifuged at 300g for 5 minutes in Fix/Perm buffer (eBioscience, UK), supernatant 
removed and then re-suspended in 2ul per 106 cells of Rat Blocking Serum (eBioscience, 
UK) to remove background of FOXP3 staining. Table 2.2 lists surface and intracellular 












Antibody Fluorophore Clone  Company 
CXCR3 PECy7 IC6 Becton Dickinson UK 
CD25  FITC IM0478U Beckman Coulter UK 
CD127 eFluor 780 ebioRDR5 eBiosciences UK 
CD8 BV510 RPA-T Biolegend UK 
CD4 PerCP CY5.5 RPA-T4 Biolegend UK 
CD3  BV605 SK7 Becton Dickinson UK 
CD14 ECD RM052 Beckman Coulter UK 
CD19 ECD J3-119 Beckman Coulter UK 
Live/Dead Fixable 
Red DYE 
ECD N/A Life Technologies UK 
Intracellular 
IL-4 APC 8D4-8 Biolegend UK 
IL-17 Pacific Blue BL168 Biolegend UK 
IFNγ AF700 4S.B3 Biolegend UK 





Table 2. 2 Antibodies for Intracellular Cytokine Staining 
68 
  
For immune checkpoint protein phenotyping, maternal and decidual samples were 
prepared for antibody staining as described previously and Table 2.3 lists the antibodies 
used. 
Antibody Fluorophore Clone  Company 
CD3 Amcyan SK7 Becton Dickinson UK 
CD8 APCCY7 SK1 Biolegend UK 
CD4 BV510 RPA-T4 Biolegend UK 
CCR7 FITC 150503 Becton Dickinson UK 
CD45RA AF700 HI100 Biolegend UK 
PD-1 BV421 EH2.2H7 Biolegend UK 
CTLA-4 PECY5 BNI3 Becton Dickinson UK 
Tim-3 PeCy7 F382E2 Biolegend UK 
Lag-3 APC FAB2319P R and D Systems UK 
CD14 ECD RM052 Beckman Coulter UK 
CD19 ECD J3-119 Beckman Coulter UK 
Propidium Iodide ECD NA Becton Dickinson UK 
Table 2. 3 Antibodies for Immune Checkpoint Proteins 
 
 2.5. Mixed lymphocyte reaction assay 
 
Fresh maternal and decidual mononuclear cells were prepared as previously described. To 
each sample 1ul per 106 cells of Easy Sep T-cell enrichment antibody mix (StemCell, US) 
was added and incubated at room temperature for 10 minutes. Then, 1ul of magnetic 
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beads per 106 of cells was added and incubated at room temperature for 5 minutes. 
Samples were re-suspended in 3mls of MACs buffer and inserted into an Easy Sep Purple 
Magnet (Stemcell, US) and incubated for 5 minutes. The T cell enriched suspensions were 
then transferred into a new FACS tubes, centrifuged at 300g for 5 minutes in MACs buffer, 
re-suspended and counted using haemocytometer. Cells then split between non T 
regulatory cell depleted and T regulatory depleted samples. Suspensions that were 
retained for T regulatory depletion were centrifuged at 300g for 5 minutes in MACs buffer 
and re-suspended into 20ul of CD25 Miltenyi Microbeads and 80ul of MACs buffer. The 
samples were incubated on ice for 15 minutes. 2mls of MACs buffer was added and 
samples were centrifuged at 300g for 5 minutes and re-suspended in 500ul of MACs buffer. 
Cell suspensions were then applied to a magnetic MACs micro-column and run through 
was collected. Samples were re-suspended to 106 cells per ml in PBS. Purity of T regulatory 
cell depleted fractions are demonstrated in Figure 2.3. 1ul of Violet cell trace dye 
(Invitrogen, UK) was added per 106 of cells and incubated at 37 degrees for 20 minutes. 5x 
the original amount of cell suspension of enriched media was added to each sample and 
incubated at 37 degrees for 5 minutes. Samples were then washed and counted.  
Cord blood mononuclear cells were isolated using the method previously described. 
5mls of red blood cell lysis buffer was added to each sample and incubated at room 
temperature for 5 minutes. Cell suspensions were then centrifuged and re-suspended in 
20mls of enriched media.  Cord blood lymphocytes were then irradiated for 3000 RADS. 
Cells and then counted using a haemocytometer.    
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Irradiated cord blood lymphocytes were added at a 2:1 ratio to each maternal and 
decidual sample in a 96 well round-bottom plate in enriched media. Each sample assay was 
carried out in duplicate, along with T regulatory cell depleted samples in parallel. Positive 
control assays were constructed using 5ul of CD3 dynabeads (Becton Dickinson, UK) in the 
place of cord blood.  Negative control assays were constructed by using enriched media in 
place of effector cells/beads. To each sample, 10 units of IL-2 cytokine was added. Samples 
were incubated for 5 days. At day three, 100ul of media per well was replaced with fresh 
media along with 10units of IL-2. 
Prior to harvesting on day 5, 1.25ug of Monensin was added to each sample and 
incubated for a further 4 hours.  Each sample was harvested and centrifuged at 300g for 5 
minutes in 5mls of PBS. Following re-suspension surface antibodes were added. After 
incubation on ice for 30 minutes, samples were centrifuged at 300g for 5 minutes in 5 mls 
of PBS and re-suspened. To each sample 100ul of 4%PFA was added and incubated on ice 
for 30 minutes. Each sample was again centrifuged at 300g for 5 minutes, resuspended and 
10ul of 4% Saponin was added. After permeabilisation for 10 minutes on ice,  intracellular 
antibodies were added. Samples were centrifuged and re-suspended in MACs buffer 








Antibody Fluorophore Clone Company 
CD3 BV605 SK7 Biolegend UK 
CD8  BV510 RPAT-8  Biolegend UK 
CD4 PerCP CY5.5 RPAT-4 Biolegend UK 
Live/Dead Fixable 
Red Stain Dye 
ECD NA Life Technologies UK 
Intracellular 
IL-10 PE JES3-9D7 eBiosciences UK 
IL-4 APC 8D4-8 Biolegend UK 
IL-17  APC-CY7 BL168 Biolegend UK 
IFNγ AF700 4S.B3 Biolegend UK 
Granzyme B FITC GB11 Biolegend UK 
Perforin PECY7 dG9 eBiosciences UK 


























Pre selection Post selection 
Figure 2. 3 T regulatory cell depletion 
Decidual and maternal T cells were depleted for CD4+ T regulatory cells 
using CD25 Magnetic Bead separation. Flow plots illustrate population of 
CD25+ T cells pre and post magnetic bead separation. 
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2.6. HY specific CD8+ T cells in Decidual and Maternal peripheral 
blood 
 
Mononuclear cells from the decidua basalis and maternal peripheral blood were prepared 
as previously described. DNA was prepared for maternal and cord blood using the DNeasy 
Blood and Tissue Kit (Qiagen, UK). Patient samples were selected, based on MHC A2 and 
B7 positivity, and whether the child was male. HLA typing was carried out. Briefly, a master 
mix of 70.87μl TDMH, 35μl nuclease-free water, 2uM of APC control primers 
(ATGATGTTGACCTTTCCAGGG) and (TTCTGTAACTTTTCATCAGTTGC) and 3.75 units of Taq 
polymerase (Bioline, UK) was prepared. 8.5μl of master mix was removed for a no DNA 
control tube. 5μl of the test DNA sample, adjusted to a concentration of 28ng/μl, was then 
added to the master mix, which was aliquoted into the PCR tubes including the HLA A2 and 
HLA B7 primer combinations, as per Table 2.5. A thermal cycler was used for the following 
heating programme; 60 seconds (95.oC), 5 cycles of 25 seconds (94.oC), 45 seconds (70.oC), 
45 seconds (72.oC) followed by 21 cycles of 25 (96.oC), 50 seconds (65.oC), 45 seconds 
(72.oC) followed by 4 cycles of 25 seconds (96.oC), 60 seconds (55.oC) and 120 seconds 
(72.oC), then 72.oC for 5 minutes before being held at 10 oC. PCR products were 
electrophoresed in 1% agarose gels containing 1X TBE buffer supplemented with 0.05% 
ethidium bromide. A 100bp molecular weight marker was added to each row so that any 
positive bands could be identified according to their size. Gels were run for approximately 
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Once A2+ and B7+ samples were identified, aliquots were prepared for flow cytometry as 
previously described. Samples were incubated with PE dextramers derived from either A2 
(FIDSYICQV) or B7 (SPSVDKARAEL) epitopes of  HY protein KDM5D (Immundex, DK),  for 20 
minutes prior to full flow cytometer staining protocol. Table 2.6 lists the antibodies used. A 
negative control dextramer was used that contained an irrelevant peptide. This enabled 
levels of background staining to be determined.  Background staining was calculated as a 
percentage of the total CD8 population and subtracted from the HY specific T cell 
frequency to determine the final frequency of HY specific T cells. Fluorescence minus one 
controls were used to determine gating thresholds. Phenotypic gating was initially carried 
out by reference to the negative dextramer population, where populations could be clearly 
Table 2. 5 HLA typing primers 
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separated due to the larger cell populations, with the same gating template, then applied 
to the dextramer positive population. 
Antibodies Fluorophore Clone Company 
CD3 Amcyan SK7 Becton Dickinson 
CD8 eFluor450 OKT8 eBiosciences 
PD-1 PECY7 EH12.2H7 Biolegend UK 
CD69 AlexaFluor 647 B176236 Biolegend UK 
CD45RA Af700 HI100 Biolegend UK 
CCR7 FITC 150503 Becton Dickinson UK 
CD14 ECD RM052 Beckman Coulter UK 
CD19 ECD J3-119 Beckman Coulter UK 
Live/Dead fixable 
red stain dye 
ECD NA Life technologies UK 




24 samples selected for the microarray consisted of 6 pairs of maternal and decidual CD4+ 
and CD8+ effector memory T cells. Mononuclear cell suspensions were prepared for each 
pair of maternal and decidual samples as previously described. Antibodies used for flow 
cytometric cell sorting were CD3, CD4, CD8 , CD45RA, CCR7 and Viability Dye. See Table 2.1 
for antibody details.  Maternal and Decidual samples were sorted into separate CD4+ and 
CD8+ effector memory samples.  Figure 2. 4 demonstrates populations that were isolated 
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following flow cytometric cell sorting. Sorted populations were deposited into separate 
eppendorfs containing PBS. RNA was immediately isolated and extracted using the Qiagen 
PLUS MICRO RNA easy kit.  The RNeasy Plus Micro Kit purifies total RNA from up to 5 x 105 
cells. Briefly, cells were first lysed and homogenized. The lysate was passed through a 
gDNA Eliminator spin column, ethanol was added to the flow-through, and the sample was 
applied to an RNeasy spin column. RNA bound to the membrane and contaminants were 
washed away. High-quality RNA was eluted in RNA free water 14 µl and quantified. RNA 
samples were immediately stored at -80 degrees. In total, 24 RNA samples were sent to 
Eurofins Genomics services. Affymetrix Pico labelling kit was used to amplify RNA, and the 

















Figure 2. 4. Gating Strategy for flow cytometric 
cell sorting of CD4+ and CD8+ EM 
Effector Memory cells were sorted based on standard 
lymphocyte forward side scatter properties following 
exclusion of doublets. Live CD3+ , CD14- CD19 were 
then selected. CD4+ and CD8+ CD3+ T cells were 
gated separately and CD45RA- CCR7- populations 
were selected for both CD4+ and CD8+ populations.   


































Flow cytometry data was analysed using FACS Diva (Becton Dickinson, UK) and statistical 
analysis was performed using Prism (GraphPad, US). Non Gaussian distribution was applied 
to all samples: Wilcoxon matched pairs signed rank test was used to identify significance 
between two sets of data, whilst Freidmans test with Dunns multiple comparison was used 
for multiple sets.  
Microarray data was analysed with the R Limma Package (Bioconductor). 
Normalisation was performed with the Loess (intra-array) and Aquantile (inter-array) 
methods. An adjusted p-value (Benjamini and Hochberg's method) of 0.05 and below was 
taken as significant for differences in gene expression. The empirical Bayesian shrinkage of 
moderated t-statistics function (eBayes) was used to generate Bayes factors for 
significantly upregulated or downregulated genes in decidua compared to maternal 
peripheral blood. Volcano plots were generated using R, and genes annotated based on 
significant Bayes value (>5). A fold change value of 1.65 (log2FC >0.7) was observed as 
significantly up/down regulated. Microarray data deposited to Array Express under 
accession number: E-MTAB-5517, website URL: www.ebi.ac.uk/arrayexpress  
Gene Set Enrichment Analysis (Broad Institute) was performed as follows: Matrices 
of differently expressed genes in decidual CD4 and CD8 effector memory T cells compared 
to maternal blood were generated using R Limma Package. Expression data was then 





2.9 Study Approval and Patients Cohort 
 
Written informed consent was obtained from all women recruited into the study. Women 
that were targeted for recruitment did not have any known pregnancy complications. 
Matched maternal blood, cord blood and placenta were collected with the approval of 
Health Research Authority- West Midlands, Edgbaston Research Ethics Committee (RG_14-
194). Table 2.7 demonstrates basic information of the patient cohort. All placental samples 
used in this study did not contain Villitis of Unknown Etiology.  
 




Chapter 3. Results  
Memory and Functional Phenotype of 
CD8 and CD4 T cells at the 3rd 





3.1. Introduction  
 
 
In early pregnancy, the decidua sees the accumulation of large numbers of specialized 
uterine NK cells (CD56bright CD16-), and their interaction with extravillous trophoblast 
plays a key role in successful placentation (Lash et al. 2011; Moffett & Colucci 2014). 
However, as pregnancy progresses the number of NK cells declines and by the third 
trimester T lymphocytes become the predominant leukocyte population (Williams et al. 
2009). Despite this, the role that decidual T cells play during healthy pregnancy is not fully 
understood. Historically, T cells at the maternal fetal interface have been described in both 
early and late pregnancy, and their phenotype and functionally only partially explained 
(Tilburgs et al. 2010; Slukvin et al. 1996; Saito et al. 1994).  Pathologies predominately 
associated with cytotoxic T cell infiltrate, such as Villitis of Unknown Etiology, are well 
characterised (Redline 2007), however, research into pathways from what is seen in 
healthy pregnancy through to destructive pathologies that are caused by T cells is distinctly 
lacking. To expand on current data, we provide comprehensive phenotypic analysis of  
CD4+ and CD8+ decidual T cells isolated from the decidua basalis and parietalis  as well as T 
cells isolated from fetal  trophoblast tissue (see Figure 2.1) , and compare these with their 
matched maternal peripheral blood and cord blood counterparts. The memory status of 
these T cells was elucidated, along with their co-expression of CD28 and CD27 to 
distinguish their differentiation stage. Functional capacity was conducted by assessing their 
ability to produce cytokines, IFNy, IL4 and IL-17, all relevant in cytotoxic responses at sights 
of allograft responses and inflammation. Lastly, CXCR3 expression, a chemokine receptor 
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previously identified as an important marker for homing of an allograft response (Croudace 
et al. 2012) expression was assessed, which provides an important insight in the potential 
of decidual T cell trafficking.  It is important to point out that T cells extracted from fetal 
trophoblast tissue might be of both maternal and fetal origin and therefore any results will 
be addressed in this context.    
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3.2. Decidual effector memory T cells dominate the T cell 
repertoire at the maternal fetal interface.  
 
 
In order to investigate and fully characterise the T cell infiltrate of healthy 3rd trimester 
placenta (<37 weeks) we collected (n=45) matched maternal peripheral blood 
mononuclear cells (PBMCs), cord blood, decidua basalis, decidua parietalis and trophoblast 
tissue, and isolated mononuclear cells. Using flow cytometric analysis, we first analysed 
memory status of CD4+ and CD8+ T cells. Figures 3.1 A and 3.1 B shows the gating strategy 
used to identify the different memory phenotypes that we analysed. CD45RA and CCR7 
was used to categorise the memory populations as follows: Naïve= CD45RA+ CCR7+; 
Central memory CD45RA- CCR7+; Effector memory CD45RA- CCR7-; EMRA= CD45RA+ 
CCR7-.  
 Figures 3.1 C, D, E and F demonstrate the distribution of CD8+ T cell memory 
phenotype in the tissues we examined. When comparing maternal CD8+ T cells to their 
decidual counterparts, there is a striking difference in the population composition. Naïve 
populations are relatively reduced in decidua parietalis (12.36%) and decidua basalis 
(14.80%) when compared to both maternal PBMCs (40.74%, p= 0.0001) and cord blood 
(87.12%, p=0.0001). Conversely, activated effector memory CD8+ T cells are significantly 
increased at the decidua parietalis (56.25%) and decidua basalis (51.25%) when compared 
to maternal PBMCs (25.87% p=0.0001), cord blood  (2.84%, p= 0.0001) and trophoblast 
(30%, p= 0.0001 and 0.0068). There are no significant differences in EMRA populations 
between maternal PBMCs, decidua basalis, decidua parietalis and trophoblast, and all 
84 
  
approach 18% of CD8+ population.  Despite the fact that a significant majority of cord 
blood CD8+ T cells possess naive phenotype, it is not completely devoid of immunological 
activity with central memory, effector memory and EMRA phenotypes comprising 6%, 2% 
and 5% respectively. Interestingly, trophoblast tissue displays significant differences 
towards decidual CD8+ T cells with increased naïve (43.9%) and decreased effector 
memory populations (30%). This might be due to contaminating cord blood cells within the 
isolated lymphocyte cells obtained from the trophoblast tissue, which may skew the 
population ratio towards a naïve phenotype.  Figure 3.2 illustrates the data using charts of 
median proportions of memory phenotype for tissue and blood samples. Differences can 
clearly be seen between the dominant effector memory phenotype (red) seen in decidual 
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Figure 3. 1. Memory Status Phenotype of CD8+ T cells at 3rd trimester of pregnancy 
 
CD8+ T cell memory status was analysed in a cohort of n=45 maternal PBMCs, cord blood, 
decidua basalis, decidua parietalis and trophoblast tissue. (A) and (B) demonstrates gating 
strategy of maternal PBMCs and decidual mononuclear cells gated on live CD3+, CD8+ and 
examined for memory status using CD45RA and CCR7 expression.  Memory status was 
classified into 4 categories: Naïve (N) CD45RA+ CCR7+; Central Memory (CM) CD45RA- 
CCR7+; Effector Memory (EM) CD45RA- CCR7-; Effector Memory RA (EMRA) CD45RA+ CCR7. 
(C) (D) (E) and (F) demonstrate Naïve, Central memory, Effector memory and EMRA 
populations respectively as percentage of total CD8 T-cells in all tissues. Lines represent 
median and interquartile range. Significance was calculated using Friedman’s test and 
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Figure 3. 2. Comparison of CD8+ T cell memory phenotypes between maternal and fetal 
tissues at 3rd trimester. 
Proportions of CD8+ memory T cell populations are shown for maternal PBMCs, cord blood 
cells, dedidua basalis, decidua parietalis and trophoblast tissue. Pie charts were generated 
by calculating the median of each CD8+ T cell memory population: Naïve- Blue; Central 




 CD4+ T cell memory status was also elucidated in decidua basalis, decidua parietalis, 
trophoblast, cord blood and maternal PBMCs. Figure 3.3 A, B, C and D demonstrate the 
comparison of different memory populations between maternal PBMCs, cord blood T cells, 
decidua basalis decidua parietalis and trophoblast T cells. As with CD8+ T cells there is a 
distinct contrast between populations of naïve and effector memory T cells in the decidual 
tissues when compared to other tissues. Maternal PBMCs, cord bood T cells and 
trophoblast T cells all had significantly increased populations of naïve CD4+ T cells, 48.4%, 
85.5%, 60.2%, compared to decidua basalis 28.78% (p= 0.0111; 0.0001; 0.0025), and 
decidua parietalis 13.55% (all p=0.0001). Maternal PBMCs had moderate levels of effector 
memory CD4+ T cells, however, decidua basalis and decidua pareitalis were still 
significantly increased, representing 53.2% (p= 0.0067) and 69.48% (p=0.0001) 
respectively. As with CD8+, CD4+ cord blood T cells, despite having a majority of naïve 
population, their effector memory, central memory and EMRA populations were still 
detected at, 3.8%, 6.2% and 3.9% respectively. CD4+ trophoblast T cells had significantly 
reduced levels of effector memory population (22.3%) when compared to other placental 
tissue, however, they did have significantly increased levels of EMRA CD4+ T cells in 
comparison to decidua parietalis, 5.1% to 2.3% respectively (p=0.01). This may suggest an 
increase in chronic stimulation or activation as T cells infiltrate into deep placental tissue. 
Figure 3.4 illustrates the data using charts of median proportions of memory phenotype 
for tissue and blood samples as in Figure 3.3. Differences in proportion of populations can 
clearly be seen between the dominant effector memory phenotype (red) seen in decidual 
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 Figure 3. 3 Memory Status Phenotype of CD4+ T cells at 3rd trimester of pregnancy 
CD4+ T cell memory status was analysed in a cohort of n=45 maternal PBMCs, cord blood, 
decidua basalis, decidua parietalis and Trophoblast tissue. Memory status was classified 
into 4 categories: Naïve (N) CD45RA+ CCR7+; Central Memory (CM) CD45RA- CCR7+; 
Effector Memory (EM) CD45RA- CCR7-; Effector Memory RA (EMRA) CD45RA+ CCR7. (A) (B) 
(C) and (D) demonstrate Naïve, Central memory, Effector memory and EMRA populations 
respectively as percentage of total CD4+ T cells in all tissues. Lines represent median and 
interquartile range. Significance was calculated using Friedman’s test and Dunn multiple 
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Figure 3. 4 Comparison of CD4+ T cell memory phenotypes between maternal and fetal 
tissues at 3rd trimester 
Proportions of CD4+ memory T cell populations are shown for maternal PBMCs, cord blood 
cells, dedidua basalis, decidua parietalis and trophoblast tissue. Pie charts were generated 
by calculating the median of each CD4+ T cell memory population: Naïve- Blue; Central 







3.2. Highly differentiated effector memory T cells are present in 
the decidua.   
 
To categorise the level of differentiation in effector memory CD8+ T cells we measured 
expression of co-stimulatory markers CD27 and CD28 in all tissue types. Figure 3.5 A and B 
demonstrates the gating strategy used to define the differentiated subtypes: EM1= CD27+ 
CD28+; EM2= CD27+ CD28-; EM3= CD27- CD28-; EM4 = CD27- CD28+. EM1 phenotype of 
effector memory T cells are memory-like, expressing less effector mediators, and are less 
mature exhibiting both CD27 and CD28 co-stimulator markers (Romero et al, 2007). These 
are significantly higher in proportion in maternal and cord blood, 54.6% and 45.47% 
respectively, when compared to decidua parietalis, 14.7% (p=0.0001), decidua basalis, 
18.63% (p=0.0001; 0.0004) and trophoblast T cells, 6.9% (p=0.0001) (Figure 3.5 C). In 
contrast, EM3 CD+ T cells that are more mature and characterised by increased cytolytic 
properties, are significantly increased at the decidua basalis and decidua parietalis, 
representing 40.62% and 41.30%, respectively, when compared to maternal PBMCs 
13.54% (p= 0.0029; 0.0005) and cord blood 0.32% (p=0.0001) (Figure 3.5 E). Interestingly, 
despite trophoblast CD8+ cells, having significantly reduced levels of overall effector 
memory population in comparison to decidual T cells, they maintain a significantly 
increased pool of EM3 CD8+ T cells, representing 34.17% of the effector memory 
population compared to maternal PBMCs (p=0.0408). Additionally, EM4 T cells, similar to 
EM1, with central memory- like properties, are significantly increased in the trophoblast, 
with a value of 34.89%, in comparison to decidua parietalis at 15.88% (p=0.0002). This 
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suggests a potential difference in functionality of T cells in placental tissue, as they transit 
through different anatomical layers (Figure 3.5 E).  
Figure 3.6 illustrates the data using median proportions of each subtype for all 
tissues. This demonstrates a significant trend of more mature effector memory subsets 
capable of cytotoxicity at the decidua, but less mature effector memory subsets in the 
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Figure 3. 5. Effector memory phenotype of CD8+ T cells at 3rd trimester of pregnancy 
CD8+ T cell effector memory status was analysed in N=45 of maternal PBMCs, cord blood, 
decidua basalis, decidua parietalis and trophoblast tissue. CD8+ Effector Memory T cells 
were gated on live CD3+, CD8+ and  CD45RA- CCR7- populations. (A) and (B) represent 
gating strategy of decidual effector memory (EM) phenotype based on CD27 and CD28 
expression: EM1 CD28+ CD27+; EM2 CD28- CD27+; EM3 CD28- CD27-; EM4 CD28+ CD27-. 
(C), (D), (E) and (F) represent EM1, EM2 EM3 and EM4 populations respectively as 
percentage of total CD8+ effector memory CD8+ T cells in all tissues.  Lines represent 
median and and interquartile range. Significance was calculated using Friedman’s test and 


























Figure 3. 6 Comparison of CD8+ effector memory phenotypes between tissues at 3rd 
trimester 
Proportions of CD8+ T cell effector memory subsets are shown for maternal PBMCs, cord 
blood cells, dedidua basalis, decidua parietalis and trophoblast tissue. Pie charts were 
generated by calculating the mean of each effector memory subset population: Em1- Blue; 
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The level of differentiation of effector memory T cells was also measured in CD4+ T cells in 
all tissues. As with CD8+ effector memory T cells, there is a similar trend of reduced 
effector function, EM1 phenotype, in maternal PBMCs, 69.52%, in comparison to decidua 
basalis 27.06%, decidua parietalis 25.15% and trophoblast CD4+ T cells, 26.50% (all p= 
0.0001) (Figure 3.7 A). Conversely, CD4+ EM3 effector memory T cells are significantly 
increased in all placental tissues, with decidua basalis, decidua parietalis and trophoblast 
representing 29.13%, 28% and 23.77% respectively in comparison to maternal PBMCs, 
1.76% and cord blood T cells, 2.32% (all p=0.0001) (Figure 3.7 C). Mirroring CD8+ EM4 
effector memory T cells, CD4 trophoblast T cells are significantly increased in comparison 
to decidua parietalis, 31.29% and 18.80% respectively (p=0.0144) (Figure 3.7 D).  
 Figure 3.8 illustrates the data using median proportions of each subtype for 
all tissues. Similar to CD8+ effector memory subsets, this demonstrates a significant trend 
of more mature effector memory subsets capable of cytotoxicity at the decidua and 
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Figure 3. 7. Effector memory phenotype of CD4+ T cells at 3rd trimester of pregnancy 
 
CD4+ T cell effector memory status was analysed in N=45 of maternal PBMCs, cord blood, 
decidua basalis, decidua parietalis and trophoblast tissue. CD4+ Effector Memory T cells 
were gated on live CD3+, CD4+ and CD45RA- CCR7- populations. (A) and (B) represent 
gating strategy of decidual effector memory (EM) phenotype based on CD27 and CD28 
expression: EM1 CD28+ CD27+; EM2 CD28- CD27+; EM3 CD28- CD27-; EM4 CD28+ CD27-. 
(C), (D), (E) and (F) represent EM1, EM2 EM3 and EM4 populations respectively as 
percentage of total CD4+ effector memory  T-cells in all tissues.  Lines represent median 
and and interquartile range. Significance was calculated using Friedmans test and Dunn 
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Figure 3. 8 Comparison of CD4+ effector memory phenotypes between tissues at 3rd 
trimester 
Proportions of CD4+ T cell effector memory subsets are shown for maternal PBMCs, cord 
blood cells, dedidua basalis, decidua parietalis and trophoblast tissue. Pie charts were 
generated by calculating the mean of each effector memory subset population: Em1- Blue; 







An additional measurement of differentiation was carried out on CD4+ and CD8+ effector 
memory T cells with the assessment of CD57. Higher levels of CD57 correlates with 
decreased telomere length and therefore is a proxy for cell division and differentiation. It 
was found that decidua basalis and decidua parietalis CD8+ effector memory T cells had 
significantly increased proportion of CD57 expressing cells, 45.2% and 43.9% respectively, 
in comparison to maternal peripheral blood CD8+ effector memory T cells, 31.95% 
(p=0026, 0.0039) (Figure 3.9 A). Decidua basalis and decidua parietalis CD4+ effector 
memory T cells had lower expression of CD57 when compared to CD8+ counterparts, 
14.1% and 12.6 respectively, yet still had significantly increased proportions compared to 














Figure 3. 9. CD57 expression on effector memory T cells in healthy 3rd trimester 
pregnancy 
The proportion of CD57+ (A) CD8+ and (B) CD4+ Effector memory T cells were measured in 
maternal PBMCs, cord blood, decidua basalis and decidua paritalis  and trophoblast T cells 
(N=20). Lines represent median and and interquartile range. Significance was calculated 

































































Following the phenotypic analysis of CD8+ and CD4+ T cells based on their memory status 
we next wanted to identify their functional capacity by measuring cytokine expression in 
decidual tissue, trophoblast, maternal PBMCs and cord blood. We measured cytokine 
levels following mitogen stimulation, to elucidate activation and cytotoxcity. Figure 3.10 A 
and B demonstrate the gating strategy to asses cytokine expression of T cells subjected to 
mitogen stimulation followed by intracellular cytokine flow cytometric staining. Figure 3.10 
C demonstrates that CD8+ T cells at the decidua parietalis and decidua basalis express 
significantly increased IFNy, 61.74% and 60.32% respectively, when compared to maternal 
PBMCs, 40.71% (p=0.0002; 0.0003), cord blood, 1.11% (both p=0.0001) and trophoblast, 
34.95% (p=0.0122; 0.0446). Interestingly, despite relatively lower levels of IL-4 in 
comparison to IFNγ, IL-4 expression was also significantly increased in decidua basalis and 
decidua parietalis, 0.94% and 1.35% respectively, in comparison to maternal PMCs, 0.34% 
(p=0.0493; 0.0121) (Figure 3.10 D). Level of Il-17 expression in CD8+ T cells was very low 
throughout all samples, approaching a median of 0.5%, and did not have any significant 
increases between samples apart from cord blood T cells (Figure 3.10 E). Decidual CD4+ T 
cells demonstrated a similar pattern of increased dual expression of IFNγ and IL-4 
expression to their CD8+ counterparts (Figure 3.11). Decidua basalis and decidua parietalis 
CD4+ T cells exhibited lower overall expression of IFNγ, 25.35% and 21.69% respectively, 
compared to CD8+, however they are significantly increased in comparison to maternal 
PBMCs, 15.84% (p=0.0006; 0.0052), cord blood, 0.30% (both p= 0.0001) and trophoblast 
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CD4+ T cells, 7.34% (both p=0.0039) (Figure 3.11 A). Decidua basalis and decidua parietalis 
IL-4 expression in CD4+ T cells was higher, 3.37% and 6.26% respectively, compared with 
CD8+, and significantly increased in decidua parietalis when compared to maternal PBMCs, 
1.67% (p= 0.0046) cord blood, 1.62% (p=0.0162) (Figure 10 B). As with CD8+ T cells, IL-17 
was not significantly increased in comparison between samples, apart from cord blood 
(Figure 3.11 C).   
In addition to the characterisation of cytokine expression and memory status of 
CD4 at the maternal fetal interface, we also wanted to assess the expression of chemokine 
receptor CXCR3, which is reported to be important in trafficking T-cells in tissue and areas 
of allo-reactivity and inflammation. We were able to detect that CXCR3 has significantly 
increased expression at the decidua parietalis, 15.40% of total CD4+ T cells, when 
compared to maternal PBMCs, 5.61% (p=0.0021), cord blood, 2.73% (p=0.0001) and 
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Figure 3. 10. CD8+ cytokine expression at 3rd trimester of healthy pregnancy 
 
Cytokine expression following mitogen stimulation of CD8+ T cells were analysed in n=30 
maternal PBMCs, cord blood, decidua basalis, decidua parietalis and trophoblast tissue. (A) 
and (B) show gating strategy of Il-4 and IFNγ in maternal PBMCs and Decidua basalis 
respectively. (C), (D) and (E) show IFNγ, IL-4 and IL-17 expression respectively as a 
percentage of total CD8+ in maternal PBMCs, Cord blood, decidua basalis, decidua 
parietalis and trophoblast. Lines and bars represent median and interquartile range. 
Significance was calculated using Friedmans test and Dunn multiple comparison test, 
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Figure 3. 11. CD4+ cytokine expression at 3rd trimester of healthy pregnancy 
 
Cytokine expression following mitogen stimulation of CD4+ T cells was analysed in n=30 
maternal PBMCs, cord blood, decidua basalis, decidua parietalis and trophoblast tissue. (A), 
(B) and (C) show IFNγ, IL-4 and IL-17 expression respectively as a percentage of total CD4+ 
in maternal PBMCs, Cord blood, decidua basalis, decidua parietalis and trophoblast. Lines 
and bars represent median and interquartile range. Friedmans test and Dunn multiple 




















Figure 3. 12 CXCR3 expression in CD4+ T cells at 3rd trimester 
 
CXCR3 expression by CD4+ T cells was analysed in n=35 maternal PBMCs, cord blood, 
decidua parietalis, decidua basalis and trophoblast. Lines represent median and 
interquartile range. Significance was calculated using Friedman’s test and Dunn multiple 
comparison test where *P=<0.05, **P=<0.01, ***P=<0.001 
  
Figure 3.12. 
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Chapter 3.4. Discussion 
 
 
So far we have established a comprehensive memory phenotype and cytokine expression 
profile of CD4+ and CD8+ T cells within placental tissue, encompassing the decidua basalis, 
decidua parietalis and trophoblast, together with donor matched maternal PBMCs and 
cord blood. The first striking feature of these data is the predominance of effector memory 
CD4+ and CD8+ T cells in decidual tissue and a reduced proportion of naive cells when 
compared to maternal, cord and trophoblast. Additionally, these decidual effector memory 
T cells are identified as having a significantly increased proportion of EM3 subtypes. These 
have been shown to have increased cytolytic properties and shortened telomere length 
(Romero et al. 2007) suggesting they have experienced allo-antigen and have undergone 
several rounds of cell division (Tilburgs et al. 2010). This is confirmed with significant 
increase of CD57 expression in decidual T cells in comparison to maternal PBMCs T cells. 
See Table 3.1 for summary of these results, comparing proportions of cell types between 






















With the measurement of increased EM3 effector memory subsets and CD57 expression 
on effector memory T cells within the decidua, we address the increase in ratio of effector 
memory to naïve T cells in comparison maternal peripheral blood is indeed a significant 
observation. Peripheral blood contains high numbers of naïve T cells and are less capable 
of entering tissues. Therefore, it could be suggested that our findings of increased 
proportions of effector memory T cells in decidual tissues does not represent specific 
Table 3. 1 Summary of T cell Memory cell types in Maternal PBMCs and 
Decidua Basalis T cells 
Breakdown of CD8 and CD4 memory populations  in maternal PBMCs and decidual T 
cells compared. Numbers represent median percentage proportion of total CD4 or 
CD8 T cells. Additionally breakdown of effector memory subsets , numbers represent 
median percentage proportion of total effector memory CD4 or CD8 T cells. Median 
percentage of CD57 expression on total effector memory T cells is also listed . 
112 
  
trafficking to the decidua and instead demonstrates that the natural occurring disparity in 
naïve and effector populations in blood and tissue. However, we have demonstrated that 
within effector memory populations between maternal PBMC and decidual samples, there 
is heightened activated cell types, suggesting that the presence of these cell populations at 
the maternal-fetal interface is significant. This activated phenotype of decidual T cells is 
also supported by the findings of elevated levels of IFNγ production upon mitogen 
stimulation, when compared to maternal, cord and trophoblast tissue. However, there is 
also additional increase of IL-4 producing an unusual profile, which may suggest the role of 
increased progesterone at this site (Lissauer et al. 2015). A Th1:Th2 shift during pregnancy 
is, despite an oversimplification, still an important concept in maintenance of a healthy 
pregnancy, and this balance is maintained not only by cellular processes distinct to 
maternal immune cells and fetal tissue, but that of maternal hormonal changes at the 
maternal-fetal interface.  Progesterone in particular is known to induce increased levels of 
IL-4 in maternal CD4+ and CD8+ T cells and, furthermore, limit their cytotoxicity (Lissauer 
et al. 2015), (Raghupathy et al. 2005a). 
Decidual T cells additionally expressed increased levels of the chemokine receptor 
CXCR3. Interestingly, Nancy et al (2012) suggested CXCR3 ligand gene silencing in decidua 
basalis of mice placenta led to reduced recruitment of T-cells to this site. This does not 
seem to be the case in human pregnancy, and highlights the importance further 
investigation of T immunology in healthy human pregnancy.  
T cells isolated from trophoblast demonstrate increased proportions of naive T 
cells, however, unlike maternal peripheral blood cells, they exhibit increased proportions 
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of EM3 and EM4 effector memory subtypes. This observation may be due to 
contamination of cord blood cells in the trophoblast isolated T cells, therefore skewing the 
level of naivety of this tissue type. However, the identification of highly differentiated 
effector T cells, suggests these cells are indeed maternal in origin and have trafficked from 
the decidua, deeper into the fetal tissue. These trophoblast T cells express reduced levels 
of cytokine, in comparison to decidual T cells. Again, this may be due to fetal blood T cell 
contamination, or indeed may be a phenotype of chronically differentiated T cells, 
identified by their CD27 and CD28 status.  
 An interesting observation is the presence of potentially antigen experienced cord 
blood cells in the form of effector memory T cells. It is thought that as the fetus develops in 
a sterile environment, the only T cell subset to be present are T regulatory cells (Mold et al 
2008). However Zhang et al (2014) have identified that these small populations of effector 
T cells in cord blood are capable of functional responses and are distinct from T regulatory 
cells. It is not known whether these are antigen specific or what endogenous functions 
would drive their differentiation; however, it is proposed that they represent a naturally 
derived pool of memory T cells able to mobilize quickly soon after antigenic stimulus. 
Other sources of potential antigenic stimulus include non-pathogenic commensal bacteria 
present in the placenta (Aagaard et al. 2014) and CD45R0+ T cells within the fetal intestine 
(Bunders et al. 2012).  
 In conclusion, we have demonstrated that within healthy term pregnancy, 
populations of CD4+ and CD8+ T cells at the decidua are enriched for highly differentiated 
and potentially antigen experienced effector memory phenotype. In addition, decidual 
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CD4+ and CD8+ T cells have increased expression of both IFNγ and IL-4, a cytokine profile 
indicative of both activation and modulation. Lastly, the significant increase of chemokine 
receptor, CXCR3 in CD4+ T cells suggest that these cells are trafficked to the maternal-fetal 
interface, which indicates an allo-reactive response. V.U.E is associated with an 
inflammatory phenotype of CD8+ T cells and our findings suggest that populations of these 
cells are also present in healthy pregnancy in the decidua. This therefore demonstrates a 
potential role of the breakdown of immune modulation at the maternal-fetal interface in 
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Our data has demonstrated that CD4+ and CD8+ T cells at the decidua parietalis and 
decidua basalis, have an increased proportion of activated and highly differentiated 
effector memory T cells, when compared to maternal PBMCs and cord blood T cells. The 
mechanisms by which decidual T cells are regulated in humans is unclear and indeed may 
depend on the potential of these cells to gain anatomical access to fetal tissue. Large 
numbers of T regulatory cells are generated during pregnancy (Rowe et al. 2012; Robert M. 
Samstein et al. 2012) and murine studies show that these are essential for fetal survival 
(Aluvihare et al. 2004a).  Inhibitory checkpoint proteins such as PD-1 and T Cell 
Immunoglobulin And Mucin-Domain Containing 3 (Tim-3) play a critical role in murine 
models of transplantation and pregnancy (Guleria, et al. 2005) and antibody-mediated 
blockade results in allograft and fetal rejection (Chabtini et al. 2013; Tanaka et al. 2007). 
Expression of these inhibitory immune checkpoint proteins has been demonstrated on 
human decidual CD8+ T cells (Wang et al. 2016) whilst Programmed Death Ligand 1 (PD-L1) 
is also expressed in human decidua  (Guleria, et al. 2005; Liang et al. 2003). For this study, 
we assessed regulatory components at the maternal-fetal interface by establishing the 
proportion of CD4+ T regulatory cell populations and the expression of checkpoint markers 




4.2 CD4+ T regulatory cells at the maternal-fetal interface 
 
 
 We analysed the percentage proportion of CD4+ CD25+ CD127- FoxP3 + T regulatory cells 
in maternal blood, cord blood, decidua basalis, decidua parietalis and trophoblast tissue. 
Figure 4.1 A represents the gating strategy used, focusing on CD25 + CD127 low FOXp3 + 
CD4+ T-cells. Figure 4.2, demonstrates that the decidua parietalis and decidua basalis 
contain increased populations of CD4+ T regulatory cells, 7.62% and 10.89% respectively, 
when compared to maternal PBMCs, 2.58% (both p=0.0001) and cord blood, 4.53% 
(p=0.011, 0.0004). This result is supported by previous data (Kahn & Baltimore 2010; 
Trowsdale & Betz 2006), suggesting increased populations of T regulatory cells in the 
decidua contribute to maintenance of immunological interaction between the mother and 
the fetus during pregnancy up to term.  
Interestingly, there are increased proportions T regulatory cells at the decidua 
parietalis in comparison to the trophoblast, 4.5% (p=0.003), suggesting reduced infiltration 




























Figure 4. 1. T regulatory CD4 T-cells at 3rd Trimester. 
Populations of T regulatory CD4 T-cells were measured in n=30 maternal PBMCs cord 
blood, decidua parietalis and decidua basalis and trophoblast. (A) represents gating 
strategy of CD4 T-regulatory cells based on CD25+ CD127 low Foxp3+ expression. (B) 
shows proportion of T-regulatory cells as a percentage of total CD4 T-cells in all tissues. 
Significance was calculated using Friedman’s test and Dunn multiple comparison test 
where *P=<0.05, **P=<0.01, ***P=<0.001 
 
Key:  M=Maternal PBMC        
C= Cord Blood               
DP= Decidua Parietalis 
DB= Decidua Basalis      
T= Trophoblast 
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4.3. Checkpoint Markers are increased on decidual T cells  
 
To further characterise an intrinsic process of regulation as opposed to extrinsic factors 
demonstrated by T regulatory cells, we analysed the level of expression of PD-1, Tim-3, 
CTLA-4 and Lag-3 on CD4+ and CD8+ effector memory T cells. These markers have been 
previously described as major immune checkpoint proteins indicating exhaustion in 
immune responses, from anti-tumour responses in solid tumours to allograft responses in 
bone marrow transplants. Using flow cytometric methods, we analysed these four immune 
checkpoint proteins in both matched maternal blood and decidua basalis effector memory 
CD4+ and CD8+ T cells (Figure 4.2 A and Figure 4.3 A respectively). All immune checkpoint 
proteins were significantly increased in decidua basalis effector memory T cells in 
comparison to maternal blood effector memory T cells. This was seen in both CD4+ and 
CD8+ subsets and was most marked in the case of PD-1, expressed on 45% and 56% of 
CD4+ and CD8+ T cells respectively (both p=0.0078). Tim-3 and CTLA-4 expression was very 
low on maternal effector memory CD4+ T cells, whilst decidua basalis expression 
significantly approached 10% (p=0.0078) along with  LAG-3  increasing from 10% to 17% 
(p=00.78). In maternal blood CD8+ effector memory T cells, Tim3 and CTLA-4 were 
expressed at somewhat higher levels   compared to CD4+. However, again, the percentage 
expression of Tim-3, CTLA-4 and LAG-3 significantly increased from 15%, 4%, 8% to 28%, 
14%, 16% respectively on CD8+ decidua basalis effector memory T cells compared to 
maternal peripheral blood counterparts (p=0.0078;0.0078;0.0156). Using Boolean analysis 
we were able to examine the pattern of co-expression of these inhibitory proteins. 
Expression of two markers was the most frequent co-expression pattern, and was 
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dominated by PD-1. PD-1 was commonly found co-expressed with either Tim-3 (47%,37%), 
CTLA-4 (32%, 21%) or Lag-3 (35%, 41%) in CD4+ and CD8+ T cells respectively (Figure 4.2 B 
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Figure 4. 2. CD4+ Effector Memory immune checkpoint protein expression at the maternal-
fetal interface. 
Expression of PD-1, Tim-3, CTLA4 and Lag-3 were measured in n=10 maternal PBMCs, and 
decidua basalis tissue. (A) demonstrates expression of immune checkpoint proteins in 
maternal PBMCs and decidua basalis tissue as a percentage of total CD4 effector memory T-
cells. Significance calculated using Wilcoxon paired sample test P=<0.05, **P=<0.01, 
***P=<0.001. (B) Boolean gating analysis shows proportions of dual positivity of immune 
checkpoint proteins expressed by effector memory CD4 T-cells in decidual tissue. 
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Figure 4. 3. CD8+ Effector memory immune checkpoint protein expression at the maternal-
fetal interface 
Expression of PD-1, Tim-3, CTLA4 and Lag-3 were measured in n=10 maternal PBMCs, and 
decidua basalis tissue. (A) demonstrates expression of immune checkpoint proteins  in 
maternal PBMCs and decidua basalis tissue as a percentage of total CD8 effector memory T-
cells. Significance calculated using Wilcoxon paired sample test P=<0.05, **P=<0.01, 
***P=<0.001. (B) Boolean gating analysis shows proportions of dual positivity of immune 
checkpoint proteins expressed by effector memory CD4 T-cells in decidual tissue.  
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Chapter 4.4 Discussion 
 
In Chapter 3 we demonstrated a strong functional capacity of decidual T cells. We were, 
therefore, particularly interested in the mechanisms that might regulate decidual T cell 
activation and, consequently, our research focussed on mechanisms of extrinsic and 
intrinsic suppression. CD4+ T regulatory cells  are deemed to play a critical role in immune 
modulation at the maternal-fetal interface (Aluvihare et al. 2004a) and several groups have 
reported an increase in T regulatory cells within decidua (Tilburgs et al. 2006). We were 
able to confirm this with a 2.5-fold increase in the proportion of T regulatory cells 
compared to maternal peripheral blood. Additionally we found that there were reduced 
populations of T regulatory cells in the trophoblast tissues. This may have an impact on 
inflammatory diseases of the placenta, if this regulatory cell type is unable to infiltrate into 
the deeper trophoblast tissue and therefore unable to modulate allo antigen immune 
responses.  
We were further interested to study the expression of inhibitory checkpoint 
proteins on decidual T cells as these proteins mediate intracellular signalling pathways that 
limit the magnitude and outcome of T cell responses by negatively regulating T cell 
activation and function. Indeed, antibodies that block inhibitory receptors have a 
transformative impact on the treatment of many forms of cancer (Topalian et al. 2012). 
We observed that the expression of four of the major checkpoint proteins, PD-1, Tim-3, 
CTLA-4 and LAG-3, increased substantially on T cells within decidua when compared to 
matched maternal peripheral blood T cells. A similar profile has been observed on decidual 
T cells in the first trimester, and indicates that this profile is established early within 
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pregnancy and is maintained throughout gestation (Wang et al. 2015). PD-L1 expression 
has been demonstrated on syncytiotrophoblast, and intermediate trophoblastic cells 
located in the chorion laeve and implantation site, which provides further support for the 
importance of this inhibitory pathway in reproduction (Veras et al. 2016). 
Combinatorial staining showed that checkpoint proteins were often expressed 
together on decidual T cell populations. PD-1 was the dominant partner in each case but 
35% of both CD4+ and CD8+ PD-1+ T cells expressed an additional checkpoint protein. This 
indicates that checkpoint expression is not redundant and, furthermore that the 
physiological importance of these patterns of expression, and their relevance in relation to 
checkpoint blockade in oncology, will need further investigation. Due to the increased 
expression of a range of immune checkpoint proteins, dominated by PD-1, the data 
suggests that CD4+ and CD8+ T cells experience chronic activation, which may lead to 
restriction of their cytotoxic activity and allo-reactive potential.   
The evidence of both extrinsic (CD4+ T regulatory cells) and intrinsic (immune 
checkpoint proteins) regulatory mechanisms at the maternal-fetal interface, and their 
relative elevated levels in comparison to peripheral blood, suggests that these are critical 
for healthy pregnancy, and in light of our findings in Chapter 3 are required to modulate 
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In Chapters 3 and 4, we established that decidual T cells are highly activated, functional, 
and differentiated; however, these cells express increased levels of immune checkpoint 
proteins. This indicates that decidual T cells cells are indeed antigen experienced and are 
potentially responding to allo-antigens present on fetal tissue. Villous cytotrophoblast and 
syncytiotrophoblast do not express MHC class I antigen presenting molecules however, 
previous reports have suggested that T cells can directly interact with extravillous 
trophoblast (EVT) and, therefore, become exposed to fetal antigen. EVT downregulates 
expression of HLA-A, HLA-B alleles, but does retain HLA-C expression (Blais et al. 2011). 
Indeed, significantly higher levels of activated T cells and T regulatory cells are induced 
within decidua of HLA-C mismatched pregnancies (Tilburgs et al. 2009). Murine models 
also suggest that fetal proteins are presented to the maternal immune system indirectly, 
through uptake and presentation by maternal antigen presenting cells (Erlebacher et al. 
2007). Due to microchimerism of fetal tissue shed into the maternal circulatory system, 
allogeneic responses are detectable both during and post pregnancy (Lissauer et al. 2012; 
Piper et al. 2009; Verdijk et al. 2004). Research directly addressing antigeneic specificity 
within human decidual is however limited (Tilburgs et al. 2010). Previous research has 
shown that during pregnancy in which the fetus is male, the maternal immune system 
elicits T cell responses specifically to HY minor antigen. These CD8+ HY specific T-cells can 
be detected during and after pregnancy, and also have cytotoxic reactivity (Lissauer et al. 
2012). The dextramers used to detect these HY specific CD8+ T cells were the A2 and B7 
epitopes derived from HY protein KDM5D.  
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Using these same dextramers we were able to detect HY specific T cells at the 
decidua. Additionally proliferation to fetal antigen was measured using a mixed 
lymphocyte reaction assay utilising matched cord blood to stimulate maternal peripheral 
blood T cells and decidual T cells.  
It is critical to state however that due to HLA-A2 and B7 not being expressed by 
extravillous trophoblast, A2/ B7 specific T cells in the decidua will not necessarily be able to 
carry out an allo-reactive response (See figure 1.5).   
 
 5.1. HY specific responses of CD8 decidual T cells  
 
Thus far, we have established highly differentiated and activated CD4+ and CD8+ T cells are 
present in the decidua. To elucidate whether this activatory pattern is, in part due to an 
allo-reactive response to fetal antigen, we analysed T cell HY specificity in pregnancies of 
male fetuses. We carried out analysis of n=9 matched maternal and decidual T cells using 
HY specific antibodies in flow cytometric analysis. Dextramers specific to A2 and B7 
epitopes derived from HY protein KDM5D were used. Maternal blood and cord blood was 
also HLA typed and samples with correct corresponding HLA type were chosen.  Figure 5.1 
A demonstrates the gating strategy used to identify CD8+ T cells that were specific to HY 
dextramer. We found that decidual basalis had a 10-fold increase in HY+ CD8+ T cells 
representing 0.6% of total CD8+ T cells when compared to maternal PBMCs, 0.06% (p= 
0.0313) (Figure 5.1 B). 
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We further phenotyped these HY specific T cells by investigating their memory, 
activation and immune checkpoint status. Figure 5.2 A demonstrates an overview of HY 
specific T cells compared to overall T cells found at the decidua. When compared to 
maternal HY specific PBMCs, effector memory populations were significantly enhanced at 
the decidua, representing 20.53% and 56.49% of HY+ CD8+ T cells respectively, p=0.017 
(Figure 5.2 D). The expression of immune checkpoint protein PD-1 was significantly 
increased in these effector memory decidual HY+ CD8+T cells, 66.06%, when compared to 
maternal PBMCs counterparts, 15.63% (p=0.0076) (Figure 5.3). We additionally measured 
the level of expression of the tissue resident activation marker CD69 and discovered that 
this was also significantly increased in the decidual effector memory HY+ CD8+ T cells in 
comparison to maternal PBMCs, 70% and 11.17 respectively (p= 0.0048) (Figure 5.3 B). 
These data suggest that T cells that are activated to fetal antigen, in this case male HY 
antigen, accumulate at the maternal-fetal interface and are of an effector memory 


























































Figure 5. 1. Fetal minor histocompatability antigen specific CD8+ T cells present in the 
decidua 
(A)  CD8 T cell responses to HY-minor histocompatability antigens were measured by 
gating on freshly isolated maternal and matched decidual live CD3+ CD8+ and HY 
dextramer+ positive cells, ex vivo ,n=9 (plots show HLA-A2 restricted dextramer results). An 
HLA specific isotype tetramer was used as –ve control. (B) HY specific CD8 T-cells are 
significantly increased at the decidua. Data shown combines results for A2 and B7 
restricted dextramers,  (Wilcoxon paired samples test, P*=<0.05). Horizontal lines represent 

































































































































































Figure 5. 2. Memory Phenotype of HY specific CD8 T-cells at the maternal- fetal interface 
(A) demonstrates memory phenotype of HY specific CD8 T-cells (in red) against a 
background of overall CD8 T cells of the decidua basalis. Memory phenotype categorised 
based on CD45RA and CCR7 expression : Naïve (N) CD45RA+ CCR7+; Central Memory (CM) 
CD45RA- CCR7+; Effector Memory (EM) CD45RA- CCR7-; Effector Memory RA (EMRA) 
CD45RA+ CCR7-. (B), (C), (D) and (E) represent Naïve, Central Memory, Effector memory 
and EMRA populations of HY specific CD8 T-cells respectively as percentage of total HY 
specific CD8 T-cells. Lines represent median and interquartile range. Significance was 
































Figure 5. 3. PD-1 and CD69 in HY specific CD8  T-cells at the maternal fetal interface 
(A) demonstrates levels of PD-1 and CD69 expression of HY specific CD8 T-cells (red) 
against a background of total CD8 T-cells in decidua basalis. (B) and (C) show PD-1 and 
CD69 expression respectively of HY specific CD8 T-cells as percentage of total HY 
specific CD8 T-cells in maternal PBMCs and decidua basalis. Significance calculated 
using Wilcoxon paired  sample test P=<0.05, **P=<0.01, ***P=<0.001 
 


























































5.3. Fetal antigen specific responses in CD4+ and CD8+ decidual T 
cells  
 
By establishing that there are increased populations of CD8+ fetal specific T cells present in 
the decidua, we next wanted to elucidate the functionality of T cells following allo-antigen 
stimulation. Using a mixed lymphocyte reaction assay, we were able to measure the 
proliferation of matched maternal PBMC lymphocytes and decidual lymphocytes when 
subjected to fetal antigen in the form of matched cord blood. Additionally, by measuring 
granzyme B on proliferating cells, we were able to detect the level of cytotoxicity of allo 
responsive T cells. Figure 5.4 illustrates how the level of proliferation is measured in this 
mixed lymphocyte reaction, where dilution of CFSE dye is measured in maternal PBMC T 
cells, decidual T cells and decidual T cells that have been depleted for T regulatory cells. 
Figure 5.5 A and 5.6 A  demonstrate that CD8+ and CD4+ decidual T cells, respectively, 
have an increased proliferative response towards fetal antigen in comparison to maternal 
PBMCs. In the case of CD8+ decidual T cells, the median proportion of proliferative cells 
14.55% compared to 10.20% in maternal PBMCs, (p=0.0039). CD4+ decidual T cells had a 
similar level of proliferation, with a median 13.20% compared to 9.15% in maternal PBMCs 
(p=0.0039).   Having already shown that T regulatory cells are increased at the decidua, we 
depleted this cell type in the mixed lymphocyte reaction to elucidate how this may affect 
the response to fetal antigen. Proliferation was significantly enhanced upon depletion of 
CD4+ T regulatory cells in both decidual CD4+ and CD8+ populations, representing an 
increase to 20.98% and 27.65% respectively (p=0.0020 and 0.0039). In addition to 
proliferation we measured expression of cytokine IL-4 and IL-10 and cytotoxic granzyme B 
on proliferating CD4+ and CD8+ maternal PBMCs and decidual T cells in the mixed 
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lymphocyte reaction. CD8+ decidual T cells expressed significantly increased levels of 
granzyme, 32% of proliferating T cells, compared to maternal PBMCs, 17.15% (p= 0.0192) 
(Figure 5.5 B). Upon depletion of T regulatory cells, expression of granzyme was 
significantly enhanced in decidual CD8+ T cells, with an increase to 37.88% (p=0.010). IL-4 
was not significantly increased between decidual CD8+ T cells and maternal PBMCs, 3.24% 
and 1.52% respectively (Figure 5.5 C). Interestingly, however, expression of IL-10 was 
significantly increased in decidual CD8+ T cells, 2.26%, in comparison to maternal PBMCs, 
0.16% ( p=0.0273) (Figure 5.5D). There was no significant increase of IL-4 or IL-10 between 
decidual T cells and decidual T cells with depleted CD4+ T regulatory cells.   Overall, 
expression of granzyme B was reduced in CD4+ T cells in comparison to CD8+ T cells, 
however, there was still significant increase between decidua and maternal PBMCs, 8.08% 
and 2.79% respectively (p=0.002%) (Figure 5.6 B). Upon depletion of CD4+ T regulatory 
cells granzyme B significantly increased to 10.88% (p=0.0068). T cells had increased 
expression of IL-4 in comparison to CD8+ T cells, and there was significant increase 
between decidua and maternal PBMCs, 11.32% and 3.42% respectively (p=0.0039) (Figure 
5.6 C). As with granzyme B, this expression was significantly increased to 14.26% 
(p=0.0039) following depletion of CD4+ T regulatory cells.  IL-10 expression was also 
increased in CD4+ T cells, again with a significant increase between decidua and maternal 
PBMCs, 3.77% and 1.27% respectively (p=0.0098)(Figure 5.6 D); however, Il-10 was not 
























Figure 5. 4. Decidual and Maternal PBMC T cells proliferating following exposure to fetal 
antigen. 
Example of flow cytometric analysis of CFSE dye dilution, which corresponds to proliferation 
of T cells following an MLR assay. Red histogram plot corresponds to maternal PBMC T 
cells, purple to decidual T cells and blue to decidual T cells which have had T regulatory cell 
depletion. Values shown are a percentage of proliferating T cells as a proportion of total T 
cells. 
 
Red:  % of proliferating CD8 + Maternal PBMC T cells  
Purple: % of proliferating CD8+ Decidual T cells 








































* * * *
A








































































G r a n z y m e  C D 8





Figure 5. 5. Proliferation and cytotoxicity of maternal and decidual CD8 T-cells to fetal 
antigen 
Mixed lymphocyte reactions were performed by matched cord blood as a stimulator and 
proliferation measured in n=10 maternal and decidua basalis T cells. (A) demonstrates 
percentage of proliferating CD8 T cells in maternal, decidua basalis and CD4 T regulatory 
cell depleted decidua basalis. (B), (C) and (D) demonstrates expression of granzyme, IL-4 
and IL-10 as percentage total of proliferating CD8 T cells in maternal pbmcs and decidua 

































































































































G ra n z y m e  C D 4





Figure 5. 6. Proliferation and cytotoxicity of maternal and decidual CD4 T-cells to 
fetal antigen 
(A) demonstrates percentage of proliferating CD4 T cells in maternal, decidua basalis 
and CD4 T-regulatory cell depleted decidua basalis. (B), (C) and (D) demonstrates 
expression of granzyme, IL-4 and IL-10 as percentage total of proliferating  CD4 T cells 
in maternal pbmcs and decidua basalis. Significance was calculated using Wilcoxon 




Chapter 5.3. Discussion 
 
This data suggests that at the maternal-fetal interface we see a functional and complex site 
of immunological interaction. We provide evidence that T cells are trafficked to the 
decidua, in the form of HY specific CD8+ T cells and are able to proliferate directly to fetal 
antigen. Previous murine work has suggested that the reason for the acceptance of the 
placenta to the uterine wall is due to immune silencing at maternal-fetal site. However, as 
demonstrated in humans, the immunological interplay is more complex. Our data shows 
that these immune responses aren't necessarily silenced, but limited due to intrinsic and 
extrinsic pathways.  
Evidence of fetal antigen specific T cells in the maternal circulatory system during 
and after pregnancy (Lissauer et al. 2012; Piper et al. 2007) suggests that there is adequate 
fetal allo-antigen present to elicit an appropriate response. In this study, we have 
demonstrated that these fetal specific T cells are indeed present at the maternal fetal 
interface, which also suggests that these T cells are actively trafficked to the placenta. It is 
important in this case, however, that extra-villous trophoblast downregulates expression 
of HLA class I A2 and B7, which correspond to the dextramer restriction used in our 
studies. This suggests that other fetal matter is responsible for instigating an HY specific 
responses in this case. Additionally, these HY A2/B7 restricted T cells will not necessarily 
respond against placental trophoblast in situ. Nevertheless, the presence of these 
restricted T cells is still of importance as once they are able to access further fetal tissue 




Given the evidence of local activation of T cells within decidua it was important to 
assess if decidual lymphocytes could recognise proteins expressed on fetal derived cells. 
Interestingly, although both CD4+ and CD8+ decidual T cells proliferated in response to 
cord blood cells, this effect was more marked for CD8+ T cells. The profile of paternally-
derived antigens presented on cord blood cells will represent only a subset of those 
expressed on all fetal tissues and, as such, we believe this assay would have 
underestimated the total magnitude of the fetal-specific immune response. Nonetheless, 
we were able to use it to demonstrate a role for T regulatory cells in the suppression of the 
decidual T cell response to fetal antigen. T regulatory cell depletion led to a 1.59 and 1.90 
fold increase in decidual CD4+ and CD8+ T cell proliferation in response to cord blood and 
demonstrates the importance of this regulatory population in suppressing maternal 
response to fetal protein. Furthermore, the reduction in regulatory T cells enhanced 
cytotoxic expression of granzyme B in both CD8+ and CD4+ T cells.  An interesting 
observation is the presence of increased expression IL-4 and IL-10 in decidual CD4+ T cells 
and increase in IL-10 in decidual CD8+ T cells. This profile suggests a protective cytokine 
response towards activation and potential evidence of a CD8+ T regulatory cell phenotype 
(Noble et al. 2006; Zhao et al. 2013). This may be an additional immunosuppressive 
response towards fetal antigen activation.  
In order to investigate the potential importance of inhibitory protein expression on 
fetal-specific decidual T cells we were able to combine HLA-peptide tetramer staining of 
HY-specific T cells with assessment of PD-1 expression. This revealed a high level 
expression of PD-1 on HY-specific cells, further implicating this checkpoint protein in an 
important role in regulating the activity of fetal specific T-cells within the decidual 
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microenvironment. Unfortunately, the low frequency of such cells prevented us from 
assessing the functional impact of PD-1 inhibition.  
The overall picture that emerges from these results is that maternal-fetal interface 
is home to functionally active and directly allo-reactive T cell populations, but both intrinsic 






Chapter 6.Results  
Transcriptomic analysis of CD4 and 







Our study has provided evidence for activated T cells located within the decidua that are 
able to elicit a response to fetal allo-antigen, express enhanced effector functions and 
increased cytotoxic potential. Additionally, we have demonstrated various potential 
mechanisms in which this cytotoxic response to the fetus may be inhibited by T cells 
themselves. However, pathologies of the placenta that are characterised by immune cell 
cytotoxic destruction, such as Villitis of Unknown Etiology  (V.U.E.), highlights the potential 
damage that can be caused by activated T cells at the maternal fetal interface in healthy 
pregnancies. Studies such as Kim et al (2009) demonstrated that the transcriptomic profile 
of V.U.E is associated with up-regulation of CXC chemokines and MHC class II molecules, 
resulting in a genetic profile similar to that of graft versus host disease and allograft 
transplantation. Unfortunately, this research was performed on whole tissue isolated RNA, 
and therefore specific transcriptomic profiles of immune cell subsets was not analysed. 
Thus far, we have only demonstrated increase in fully transcribed proteins present on the 
surface of T cells through use of flow cytometry. To provide us with a greater 
understanding of the nature of any fetal allo-antigen response, analysis of the 
transcriptome of CD4+ and CD+ effector memory T cells reveals targets and pathways that 
might not have been fully elucidated with cellular based assays.  
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6.1. Transcriptional analysis of CD4+ and CD8+ effector memory T-
cells reveals a strong response in interferon signalling within 
decidual T cells 
 
In order to comprehensively describe the differences between the decidual and peripheral 
effector memory T cell population we went on to perform a transcriptional analysis using a 
microarray of CD4+ and CD8+ effector memory T cells purified from decidual tissue and 
matched maternal peripheral blood. In total of 6 sets of patient samples were analysed 
each comprised of paired maternal and decidual CD4+ effector memory T cells and CD+8 
effector memory T cells. Statistical significance of upregulated of downregulated genes 
was calculated using a dual methodology of Bonferroni-Hochburg corrected p values 
followed by empirical Bayesian ranking. This provided us with a Bayes value, where >5 was 
regarded to be statistically significant. Additionally, fold changes greater than 1.65 (log2FC 
>0.7) were deemed significantly upregulated or downregulated. See Figure 6.1 for a 
breakdown of number of genes up or downregulated in CD4 and CD8 decidual T cells.   26 
and 31 genes were significantly upregulated in the decidual CD4+ and CD8+ T cells 
respectively. In addition, 6 genes were shown to be downregulated within decidual CD4+ 
effector T cell. (Figure 6.2 and 6.3).  
 Eight genes, RSAD2, IFI6, IFI27, IFI44L, IFIH1, EIF2AK2, DDX60 and USP41, were 
upregulated in both CD4+ and CD8+ from decidua. Interestingly, these are all associated 
with the cellular response to interferon signalling.  RSAD2, also known as viperin, is an 
interferon-inducible antiviral protein induced by type I and type II interferon. It also 
facilitates T cell receptor (TCR)-mediated GATA3 activation and optimal T helper 2 (Th2) 
cytokine production (Lim et al. 2012; Hata et al. 2009). IFI6, IFI27, IFI44L and IFIH1 are all 
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interferon-inducible genes that are associated with a type 1 interferon signature, and 
EIF2AK2 is a double-stranded RNA-dependent protein kinase R that is amongst the first 
proteins to become activated following viral infection or stress signalling (Wang et al. 
2014).  DDX60, also known as DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 (DDX60), is a 
cytosolic DNA sensor and RNA helicase that is involved in RLR-mediated type I IFN 
production after viral infection and mediates viral RNA degradation via the RNA exosome 
(Oshiumi et al. 2016). The function of USP41 is unknown, but it has high sequence 
homology with USP18, (USP)-18, a Ubiquitin-specific peptidase which acts as a negative 
regulator of interferon α/β responses (Pinilla-Vera et al. 2016).  Several differences were 
observed in the transcriptional profile between CD4+ and CD8+ T cells within decidua 
including the OAS1, OAS2 and OAS3 genes, which encode members of the 2-5A synthetase 
family involved in the innate immune response to viral infection and which were 
upregulated by approximately 2-5 fold in CD8+ decidual T cells. A specific finding of 
interest within CD4+ T cells was a marked increase in expression of the CLIC1 intracellular 
chloride channel, which has not previously been reported to be expressed in decidual T 
cells.  
Of the 6 significantly downregulated genes in CD4+ effector memory decidual cells, 
3 are described as non-coding RNAs. Despite an absence of documented functional 
relevance in T cell immunology, these non-coding RNAs may have a role in epigenetic 
regulation of gene expression, and the downregulation of these genes may be distinct in T 
cell activation in the decidua. Indeed, a recent study has suggested several upregulated 
and downregulated micro RNAS have a potential role in the decidua of patients of 
recurrent miscarriage (Dong et al. 2014).   
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 The genes encoding Galectin-1 and Galectin-9 demonstrated increased expression 
in decidual CD4+ and CD8+ effector memory cells respectively. Galectin-1 expression has 
been previously observed on decidual NK cells and galectin-9 is also present on T 
regulatory cells in pregnancy (Koopman et al. 2003; Meggyes et al. 2014). As such, this 
particularly high expression by effector T cells within decidua is further evidence that these 
proteins are important immune-regulatory molecules during pregnancy (Deák et al. 2015). 
Further interrogation of the role of the differentially expressed genes using the Database 
for Annotation, Visualization and Integrated Discovery (DAVID) and Reactome identified 
several pathways that were significantly upregulated, most notably “interferon signalling”,  
‘immune responses to virus’ and ‘regulation of apoptosis’ (Table 6.1 and 6.2).   
 
 
Figure 6. 1 Summary of Up/Downregulated genes in Decidual vs Maternal Effector 
Memory T cells.  
In decidual CD4 effector memory T cells, there were 26 significantly upregulated and 6 
downregulated genes  when compared to maternal blood effector memory T cells. There were 31 
significantly upregulated genes in decidual CD8 effector memory T cells. 8 significantly upregulated 




We compared the genes that comprised the response to interferon and response to 
virus/RNA binding ( see Table 6.1 and 6.2) gene list in both decidual CD4 and CD8 effector 
memory T cells, with gene sets in the Molecular Signature Database (Broad Institute). 
Specifically we computed overlaps of our gene lists with the C7 collection, a database of 
4872 gene sets generated by manual curation of published studies in human and mouse 
immunology. There were no overlaps between our gene lists and gene sets derived from 
experiments on T cells in other tissues. This suggests that the specific gene signatures 
discovered in our microarray data regarding interferon signalling and RNA binding is 
unique to effector memory decidual T cells, and is not necessarily a component of 





















Figure 6. 2. Transctriptome of Effector memory CD4 T cells in Maternal PBMCs and 
Decidual Tissue 
RNA was isolated from maternal and decidual CD4 effector memory T-cells and analysed 
using HTA 2.0 microarray (n=6). Volcano plots were generated, based on individual probes 
log fold change and P value associated with reproducibility of these changes between 
Maternal and Decidual T-cells. Bayesian analysis was used to calculate genes with 
significantly different expression profiles, where red represents upregulation and blue 
down regulation. Genes were appropriately annotated in order of Bayesian value (B=>5). 
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 Table 6. 1. Significantly upregulated genes in effector memory CD4+ decidual T cells 
Genes that had significantly differential expression in decidua were entered into 
Database for Annotation, Visualisation and Integrated Discovery (DAVID) and 
significantly upregulated pathways were generated (Bonferroni corrected p=<0.05). 
The seven coding exons of CLIC1 are also categorised as well as non-coding RNAs. Red 
indicates upregulated genes, blue indicates downregulated genes. Bold and 
underlined indicates upregulated genes in both CD4+ and CD8+ effector memory T 



























































Figure 6. 3. Transctriptome of Effector memory CD8 T cells in Maternal PBMCs and 
Decidual Tissue 
RNA was isolated from maternal and decidual CD8 effector memory T-cells and 
analysed using HTA 2.0 microarray (n=6). Volcano plots were generated based on 
individual probes log fold change and P value associated with reproducibility of these 
changes between Maternal and Decidual T-cells. Bayesian analysis was used to 
calculate genes with significantly different expression profiles. Genes were 
appropriately annotated in order of Bayesian value (B=>5). Annotated dots refer to 
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Table 6. 2. Significantly upregulated genes in effector memory CD8+ decidual T cells 
Genes that had significantly differential expression in decidua were entered into Database 
for Annotation, Visualisation and Integrated Discovery (DAVID) and significantly 
upregulated pathways were generated (Bonferroni corrected p=<0.05). Red indicates 
upregulated genes, blue indicates downregulated genes. Bold and underlined indicates 
upregulated genes in both CD4+ and CD8+ effector memory T cells. Letter annotation for 




6.2 Targeted analysis of decidual effector memory T cell 
transcriptome 
 
We also examined the combined pattern of gene expression within specific immune 
response and regulatory pathways. Gene Set Enrichment Analysis demonstrated that  gene 
sets and pathways associated with apoptosis, allograft rejection, negative regulation of 
activation of T cells and IFNγ and IFNα  responses were enriched in decidual CD4+ and 
CD8+ T cells.  
 Gene Set Enrichment Analysis allows for measurement of subtle increases and 
decreases in large groups of genes across entire microarray data sets.  These trends of 
large numbers of differentially expressed genes are then measured against a data base of 
“gene sets”. Any significantly enriched gene sets discovered during the analysis represent 
pathways that are potentially upregulated. Additionally, specific differentially expressed 
genes can contribute to the core enrichment of a gene set, allowing for discovery of 
upregulated candidate genes that might have been missed in conventional microarray 
analysis of significantly upregulated genes. Table 6.3 lists the significantly upregulated 
gene sets in both CD4 and CD8 decidual effector memory T cells along with the top 30 
differentially expressed genes contributing to core enrichment of each gene set.   
 Consistent with our earlier findings, genes encoding checkpoint proteins Lag-3, Tim-
3, CTLA-4 were differentially expressed in decidual effector CD8+ and CD4+ T cells, in 
comparison to peripheral blood, and contributed to the core enrichment of negative 
regulation of T cell activation gene sets and pathways within decidual T cells. In addition to 
these, another differentially expressed gene coding an inhibitory protein of particular 
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interest was T cell Immunoreceptor with Ig and ITIM domains (TIGIT). This is a recently 
discovered immune checkpoint protein (Yu et al. 2009), which is seen to be highly 
expressed in effector CD4 and CD8 T cells as well as NK cells and regulatory T cells (Lozano 
et al. 2012; Joller et al. 2014; Johnston et al. 2014). Its cognate ligand is CD155 and upon 
binding enacts similar inhibitory function that binding CTLA-4 causes. Indeed, TIGIT 
competes with CD226 for CD155 mirroring the CTLA-4/CD28 pathway. TIGIT and its role in 
tumor infiltrating lymphocytes has been thoroughly researched and various inhibitory 
pathways involving TIGIT have been discovered that contribute to immune senescence at 
the tumor microenvironment. Firstly, TIGIT on CD4 or CD8+ T cells has been shown to bind 
to dendritic cells, which in turn elicits downregulation of CD86, causing reduced 
costimulatory function, and increased expression of IL-10 (Yu et al. 2009). TIGIT present on 
CD4+ T regulatory cells can bind to CD8+ T cells and suppress effector function, as well as 
skew CD4+ T cells to a Th2 phenotype (Kourepini et al. 2016; Kurtulus et al. 2015).Lastly, 
TIGIT expressed on tumor cells has shown to directly inhibit CD8+ T cell cytotoxicity 
(Johnston et al. 2014). Currently, there have been no studies addressing TIGIT and its effect 
on T cell fetal antigen responses in the placenta; however, due to its highly suppressive 
mechanism in T cell inflammatory responses, it could be highly relevant in 
immunotolerance at the maternal-fetal interface. 
Genes encoding Caspase 3, IL-2 receptor, CCR5, Granzyme B, CXCR3,  IFN-γ, and 
CXCL13 were also differentially expressed in CD4+ and CD8+ decidual effector memory T 
cells and contributed to the enrichment of apoptosis and allograft response gene sets 
within decidual T cells respectively. Previous research by Kim et al. (2009) demonstrated 
that CCR5 and CXCL13 were both upregulated in placental tissue of V.U.E. and through our 
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own analysis of decidual CD4+ and CD8+ T cells, we find that these chemokine receptors 
and ligands both are present in term healthy pregnancy.  
TNF-related apoptosis-inducing ligand (TRAIL) was also differentially expressed in 
decidual effector memory CD8 and CD4 and contributed to enrichment of apoptosis gene 
set pathway. Similar to another apoptosis signalling factor, FAS ligand (FasL) binding of 
TRAIL to its cognate receptors, induces extrinsic pathway of apoptotic signalling. During 
pregnancy it has been shown that both trophoblast and fetal derived exosomes exhibit 
TRAIL, resulting in immunomodulation against activated immune cells (Svensson-Arvelund, 
Ratnesh B. Mehta, et al. 2015; Stenqvist et al. 2013). Also, expression of TRAIL by activated 
T cells themselves, has shown to be an important factor against viral infected cells and 
tumor cell clearance as well as haematopoiesis (Falschlehner et al. 2009; Brincks et al. 
2008). There has been no research addressing the specific role of TRAIL expression on T 
cells at the maternal-fetal interface; however, given that our data indicates that Caspase 3, 
an important downstream factor of apoptosis, is also upregulated, it might function in an 
immunomodulatory role.   
Our data indicates that CD4+ and CD8+ T cells at the maternal-fetal interface 
demonstrate a unique transcriptional profile including a dominant response to interferon 
signalling and activation of inflammatory pathways, but also express a wide range of 
proteins associated with immune activation and regulation. Figure 6.4 highlights enriched 



























































of Cell Activation 
(NES:1.45, FDRq: 
0.151) 
IFNG IFI44L IFI44L TNFSF10(TRAIL
) 
CTLA4 
IL2RA RSAD2 RSAD2 GZMB IL2RA 
CCR1 IFIT1 LAMP3 PMAIP1 XCL1 
CXCL13 CMPK2 CMPK2 FASLG LGALS9 
TLR3 IFIT3 IFIT3 PSME2 HAVCR2 (TIM-3) 
STAT1 OAS3 USP18 LMNB1 TNFSF4 
IRF4 XCL1 OAS1 FAS LAG3 
WARS USP18 IFI27 PSMA6 CD274 
CSF1 CD38 PLSCR1 PSMD14 CEACAM1 
GZMB IFI27 IFI44 BCL2L11 SAMSN1 
CD80 PLSCR1 PARP9 PSMA2 SLA2 
FASLG IFI44 IFIT2 PSMB5 FAS 
CCR5 IFIT2 MX1 BCL2 TIGIT 
IL1B MX1 EIF2AK2 PSMA4 ANXA1 
FAS TNFSF10 DDX60 VIM IL4R 
GCNT1 EIF2AK2 IFIH1 CASP7 IL10 
HIF1A DDX60 EPSTI1 PSMB6 HLA-DRB5 
CCL7 IFIH1 RTP4 LMNA CASP3 
NCF4 EPSTI1 SAMD9L PSMB3 HLA-DRB1 
CAPG RTP4 HERC6 CASP3 JAK3 
TAP2 SAMD9L PNPT1 PSMA3 SERPINE2 
ICAM1 HERC6 BST2 BMF HLA-DRB4 
IL4R STAT1 IFI35 PSMC1 IFNA2 
TAP1 IRF4 OASL PSMA1 IRF1 
CD2 PNPT1 PARP12 PSME1 HLA-DRB3 
IL10 XAF1 LAP3 PSMB9 PDCD1LG2 
CD7 BST2 ISG15 PSMD5 CD74 
CXCR3 IFI35 WARS BAX BCL6 
DARS OASL IFITM1 PSMD8 LGALS3 
Table 6. 3 Gene Set Enrichment Analysis  
Gene set enrichment analysis (Broad Institute) was performed to asses enriched gene sets 
present in microarray data of CD4 and CD8 effector memory decidual and maternal T cells. 
Enriched gene sets (<FDR 0.25) are listed along with top 30 genes from microarray data that 







Microarray analysis revealed a wide range of genes whose transcriptional activity was 
differentially expressed in decidual effector memory CD4+ and CD8+ T cells compared to 
peripheral blood. Significantly, genes associated with interferon signalling receptivity were 
markedly increased in both CD4+ and CD8+ decidual T cells. Interestingly, high levels of 
interferon-γ have been reported within decidual tissue (Chard et al. 1986) and this appears 
to be localised primarily within cells of the monocyte linage (Khan et al. 1990). Interferon 
production is driven most strongly by viral infection and these observations raise the 
question as to whether or not localised viral infection is found within decidual tissue. 
Indeed, we would suggest that endogeneous retroviruses (ERV) are the likely trigger for 
interferon production within decidua. ERVs represent more than 8% of the human genome 
(Bannert & Kurth 2004; Tristem 2000) and became integrated into the mammalian genome 
between 40 and 0.1 million years ago via retroviral infection of germ cells (Turner et al. 
2001). Notably, a protein encoded from the env gene of ERVW-1 called Syncytin-1 has an 
essential role placentogenesis (Blond et al. 1999; McCoy et al. 2000) through formation of 
the syncytiotrophoblast. Furthermore, Syncytin-1 has been shown to be released into the 
periphery via placental microvesicles that are able to elicit a T cell response (Holder et al. 
2012) and substantial expression of proteins from the endogenous retrovirus HERV-K has 
been demonstrated in villous and extravillous cytotrophoblast (Kämmerer et al. 2011). In 
the context of the functional relevance to this type 1 interferon signalling, interferon-α is 
known to be a significant antiangiogenic factor, resulting in downregulation of 
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proangiofactors including VEGF (Denny et al. 2007). This can result in impairment of 
vascular remodelling in the case of lupus patients, and it has been suggested that this 
interferon response can be localised to the decidua resulting in malplacentation and 
pregnancy complication (Andrade et al. 2015). Together this data may implicate decidual T 
cells in a role that modulates further vascularisation as pregnancy progresses.  
 Interestingly, our microarray results also revealed substantial upregulation of the 
CLIC1 gene in decidual CD4+ effector T cells. This chloride channel protein has garnered 
much attention recently within solid-tumors where its expression is associated with 
metastasis and invasion (Lu et al. 2015; Zhao et al. 2015; Tian et al. 2014). CLIC1 is a 
metamorphic protein that can shift between two or more stable conformations and its 
expression is increased by hypoxia where it acts to regulate cell function through the ROS-
mediated p38 MAPK signalling pathway (Zhao et al. 2015; Averaimo et al. 2010). It is 
known that the placenta develops in a hypoxic environment, and that Hypoxia Inducible 
Factors (HIFs) play a key role in modulating placental cell function under low oxygen 
conditions (Patel et al. 2010). Our work identifies a new role for CLIC1 in reproductive T cell 
immunology and demonstrates that more research will be required to establish its 
physiological function in decidual CD4+ effector memory T cells. Of note CLIC3, which is 
another member of the CLIC family, has been shown to be important in pre-eclampsia, 
where increased levels at the syncytiotrophbast layer result in disruption of membrane 
potential and downstream apoptosis (Murthi et al. 2012). 
Transcription of the LGALS1 gene which encodes Galectin-1 was upregulated in 
CD4+ T-cells. Galectin-1 is expressed by both endometrial and uterine NK cells during 
164 
  
pregnancy (Koopman et al. 2003), and is involved in generation of tolerogenic dendritic 
cells (Ilarregui et al. 2009). Intracellular expression of galectin 1 is also observed in 
activated T cells (Blaser et al. 1998; Fuertes et al. 2004) where it acts to increase sensitivity 
to the action of extracellular Galectin-1, in which it activates downstream apoptosis (Deák 
et al. 2015).  In contrast, decidual CD8+ T cells upregulate galectin-9, a ligand of Tim-3 
which is involved in both chemo-attraction and apoptosis (Rabinovich & Toscano 2009) as 
well as inhibition of chronic inflammation (Zhu et al. 2005). Expression of Galectin-9 by T 
regulatory cells promotes stability of an immunosuppressive phenotype (Wu et al. 2014)  
and its expression by decidual CD8+ T cells may therefore increase effector cell regulation 
following interaction with Tim-3 (Deák et al. 2015). Through Gene Set Enrichment Analysis, 
we also discovered other immune markers that have not been fully examined in the 
context of pregnancy and fetal allo-antigen responses. Immune checkpoint protein, TIGIT 
and death receptor ligand TRAIL could play essential roles in T cell modulation at the 
maternal-fetal interface given their similar mechanisms to well-studied immune proteins in 
pregnancy, such as PD-1 and FAS-L respectively.  
To address the subject of whether our microarray data represents a general pattern 
of upregulated genes in tissue  in comparison to blood we performed a database search of 
genes found to represent upregulated pathways in decidual T cells from our microarray 
data (Response to Interferon and Response to Virus) against the Molecular Signature 
Database. We were unable to find similar upregulated lists of genes in other tissues from 
the  database of 4872 experimental data. This gives us increased confidence that our data 
demonstrates a gene signature specific to the decidual environment, rather than that of T 
cells that have infiltrated tissues.  
165 
  
The transcriptomic analysis of decidual effector CD4+ and CD8+ T cells has revealed 
several highly novel mechanisms at work within the maternal-fetal interface. With further 
investigation these could prove to play a previously unidentified, yet critical, role in the 










The human placenta is a key interface at which the maternal immune system interacts with 
the allogeneic fetus. Despite the evolution of mechanisms of fetal tolerance including MHC 
class I and Class II restriction on fetal trophoblast and involvement of tolerogenic uterine T 
regulatory cells and uterine NK cells, it has been widely reported that immune 
dysregulation during pregnancy has detrimental effects. Indeed, fetal cells are able to cross 
the placenta into maternal circulation, and during pregnancy the maternal immune system 
is able to elicit a T cell response to fetal antigens (Lissauer et al. 2012). Our research has 
characterised CD4+ and CD8+ memory subsets at the maternal-fetal interface as well as 
maternal PBMCs and cord blood populations, and have shown that highly differentiated 
effector memory T cells are enriched in the decidua. Intracellular cytokine profiling also 
demonstrates that decidual T cells have increased expression of cytotoxic cytokine IFNγ. 
Despite the presence of this activated and potentially cytotoxic profile, we also have 
provided evidence that the decidua has increased populations of CD4+ T regulatory cells 
levels relative to maternal PBMCs. In addition to this regulatory cell population at the 
maternal-fetal interface, we demonstrated that decidual effector memory T cells had 
increased expression of immune checkpoint proteins PD-1, Tim-3, Lag-3 and CTLA-4, 
suggesting a mechanism of exhaustion in this subset of cells. Given the presence of 
activated T cells at the decidua, we examined T cell fetal specificity and discovered that 
CD8+ T cells that were specific to the male HY antigen in pregnancies with male fetuses 
were significantly increased in the decidua. Additionally, following mixed lymphocyte 
reaction assay using cord blood as a source of fetal antigen, we demonstrated that 
decidual T cells had an increased proliferative and cytotoxic expression of granzyme B 
relative to maternal PBMC. Following depletion of CD4+ T regulatory cells, this proliferative 
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and cytotoxic response was significantly enhanced. Lastly, through the application of a 
microarray of CD4+ and CD8+ effector memory cells derived from decidua and matched 
maternal PBMCs, we were able to determine a novel transcriptomic response to type 1 
interferon, and further clarified pathways of both activation and exhaustion that were 
eluded to in our flow cytometry analysis.   
The presence of large numbers of potentially fetal-reactive effector T cells found in 
the decidua of healthy pregnancies at term has a particular consequence in the role of allo-
reactive associated disorders such as V.U.E. It is now recognised that V.U.E. may result 
from the recognition of fetal tissue by the humoral and cellular components of the 
maternal adaptive immune system (Tamblyn et al. 2013). The clinical expression of V.U.E. 
includes fetal growth restriction, preterm birth and recurrent pregnancy loss. In these 
cases the histology is characterized by a heavy maternal inflammatory cell infiltrate of T 
cells and macrophages with a predominant CD8+ profile (Redline 2007). This is associated 
with focal inflammation of fetal villi, and it is noteworthy that this profile is present to a 
modest extent in many normal pregnancies. The evolutionary balance of fetal-specific T 
cell responses may be delicately poised to permit successful reproduction in the great 
majority of cases, whilst avoiding intensive local or systemic maternal immune 
suppression. 
Previous studies have established that differentiated T cell populations exist in 
healthy decidua at term (Tilburgs et al 2010). However, to date, a comprehensive 
phenotype of both CD8 and CD4 T cells, combined with functional, regulatory, specificity 
and novel transcriptional profiles provides a solid foundation of work that can be taken 
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further in order to identify T cell-modulated pathways in pregnancy complications.  Despite 
V.U.E being detected in healthy pregnancy, our study did not detect any cases of V.U.E in 
any of our sample collection. Therefore an important next step would be  to assess T cell 
phenotypes in pregnancies affected by various pathological complications that are also 
correlated with V.U.E. Pathologies that could be easily targeted in a clinical setting would 
be women experiencing either pre-eclampsia or gestational diabetes. Presence of V.U.E. 
has been correlated with instances of preeclampsia (Tamblyn et al 2013) and despite its 
association with poor decidualisation during 1st trimester, it is nevertheless important to 
elucidate how effector T cell populations differ in cases of pre-eclampsia and how they 
may contribute to destructive villitis towards term of pregnancy. Previous studies have 
shown that women with gestational diabetes have higher T cells of an activated phenotype 
(CD69+ and HLA-DR+), and reduced CTLA-4 expression (Pendeloski et al. 2015) in their 
peripheral blood. This gives credence to the study of decidual T cells in the context of such 
pregnancy complications, and how it may affect the placental environment and fetal 
tolerance. 
 The role of T cells at the maternal-fetal interface is an often overlooked area of 
research, with potentially great implications for the onset of various pregnancy 
pathologies. Historically, leukocyte populations at the decidua are studied in the context of 
tissue remodelling, the invasion of trophoblast of the uterine wall and the role that NK 
cells and macrophages have on this during the first trimester. However, our research has 
demonstrated that in the third trimester of healthy pregnancy, the maternal-fetal interface 
has highly enriched populations of functional, differentiated and fetal specific T cells, 
suggesting that this immune population could play a role in multiple pregnancy 
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complications. A critical next step would be to comprehensively assess the T cell 
phenotype during the 1st and 2nd trimester of healthy pregnancy. Despite evidence of 
lower total T cells counts in the placenta at these time points, it would be of significant 
interest to track how activated and fetal specific T cell populations accumulate throughout 
gestation.  
A limitation of this study is the narrow perspective of the role of T regulatory cells 
have within the decidua. Despite demonstrating that there is an increased proportion in 
decidua, and that after depletion in an MLR setting resulted in increased proliferation of 
effector T cells, it should not be assumed that their function is based entirely on 
recognition of fetal antigen. Indeed, there is an emerging role of T regulatory cells in 
maintenance of metabolism and tissue repair. Feuerer et al. (2009) demonstrated in 
murine models, that T regulatory cells from abdominal fat (visceral adipose tissue), were 
transcriptionally distinct from lymphoid organ T regulatory cells and were significantly 
reduced in insulin resistant mouse models of obesity. Additionally loss and gain of function 
studies influenced the inflammatory environment of adipose tissue and response to 
insulin. In vitro experiments demonstrated the effect of IL-10 on cultured adipocytes and 
its function on reducing synthesis of inflammatory mediators and insulin response. In 
relation to tissue repair, Burzyn et al. (2013) in murine models, described a phenotypically 
distinct population of T regulatory cells that accumulate to sites of skeletal muscle injury 
coinciding with a switch of M1 macrophages to tissue repair M2 macrophages. A critical 
factor in these skeletal muscle T regulatory cells was expression of amphiregulin, which 
functions to improve muscle repair. It is likely that T regulatory cells located at the 
maternal-fetal interface perform a multitude of homeostatic functions, beyond that of 
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limiting antigen specific responses, including maintenance of localised cellular metabolism 
and assisting tissue repair during placental growth. It should be noted however that human 
research into these specific alternate roles of T regulatory is limited, especially in 
pregnancy.  
One focus of this study was HY specific T cells in the decidua; however, this greatly 
limits the potential response to other mHAGs inevitably present on fetal matter, including 
the trophoblast. In addition to HY proteins expressed on placental EVT cells (KDM5D, 
DDX3Y, and RPS4Y1) autosomal mHAGs HMHA1, KIAA0020, and BCL2A1 were also shown 
to be expressed (Holland et al 2012). Moreover, HMHA1, which is also highly expressed on 
syncytiotrophoblast has been shown to elicit an antigen-specific CD8+ T cell response in 
haematopoietic stem cell transplantation (van Halteran et al 2009). However, as with many 
arguments over whether decidual T cell are able to directly respond to fetal antigen, 
syncytiotrophoblast cells do not express any MHC molecules and, therefore, lack the 
capacity to directly present mHag peptides to T cells. It is hypothesised that despite these 
antigens being processed and presented to T cells, subsequently, these T cells will be 
unable to respond in an allo-reactive nature. However, there are several caveats to this 
assumption which may explain how cytotoxic damage of the placenta arises, especially in 
the case of V.U.E. Even though the syncytiotrophoblastic layer is considered a barrier 
between the maternal tissue and intra-placental layers, this does not discount the 
presence of focal damage or gaps due to shedding of layers during infiltration and 
expansion of the placenta or upregulation of adhesion molecules (Redline 2007, Tamblyn 
et al 2013). Consequently, this may allow T cells to enter the placental tree and, thereby, 
elicit further responses. Specifically, in the case of CD8+ T cells, they will be able to interact 
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not only with HLA-C expressing extravillous trophoblast, but also non-trophoblastic stromal 
bodies including endothelial cells, fibroblasts and fetal derived macrophage Hofbauer cells. 
CD4+ T cells would also be able to interact with MHC class II expressing Hofbauer cells and 
help prolong a cytotoxic response. Our research has demonstrated consistently that T cells 
with cytotoxic potential are situated in the decidua, and are fetal specific, even in a healthy 
pregnancy. This gives significant weight to the hypothesis that pathologies like V.U.E. are a 
result of a breakdown of the immunomodulatory mechanism. Indeed, as demonstrated 
there are multiple targets for this potential breakdown, which could be carried forward for 
further investigation, such as the significance of expression of multiple immune checkpoint 
proteins present on decidual T cells.  
The presence of fetal-reactive effector T cells at the decidua are likely to have been 
primed following systemic transfer of fetal cells and placental debris into the maternal 
circulation, which may involve either local or systemic presentation within lymphoid tissue. 
It should be noted that the HLA-peptide multimers used in this study included the HLA 
alleles of HLA-A2 and HLA-B7, and these proteins are not expressed on fetal 
syncytiotrophoblast or extravillous trophoblast (EVT). As such, it remains possible that 
anatomical limitations may serve to largely limit the potential interaction between fetal-
specific T cells and fetal tissue. In this regard, it will be important in future studies to 
investigate the presence and function of fetal-specific cells restricted by HLA-C and HLA-G, 
which are the only polymorphic HLA molecule expressed on EVT. Indeed, in humans, HLA-C 
mismatched pregnancies were shown to induce CD4+ T regulatory cells in decidual tissue, 
whereas HLA-C-matched pregnancies did not (Tilburgs et al 2009). It was suggested that 
these findings indicated that paternal MHC/HLA-C molecules were specifically recognized 
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by maternal leukocytes, however HLA-C specific dextramer was not applied. Despite this, 
our research provides some of the first evidence of CD8+ specific to HY antigen being 
present at the maternal-fetal interface. Investigation into whether MHC/HLA-C specific 
CD8+ T cells play a clinical role in recurrent miscarriages and V.U.E, and the role of T 
regulatory in managing this allo-reactive response will be a critical next step in 
understanding the mechanism of T cell tolerance to the allogeneic fetus.  
  One argument against the relevance of the presence of T cells at the decidua, is 
that they are merely transient or trafficked non-specifically to an area undergoing 
significant tissue remodelling. The focal nature of V.U.E. contradicts this mechanism, as a 
non-specific infiltration would result in a diffuse pattern of infiltration. Our research also 
demonstrates T cell specific to fetal antigen have an increased proliferatory response to 
fetal cells, suggesting mechanisms of antigen presentation and directed trafficking.  In 
order to clarify specific trafficking of decidual T cells and allo-antigenic responses, further 
research is needed to analyse the TCR clonality of the decidual T cell. The presence of 
reduced clonotypes at the maternal fetal interface would suggest increase in specific T cell 
trafficking rather than a diffuse broad populations. Additionally, TCR analysis could be 
performed following MLRs involving maternal T cells responders and fetal cell effectors. 
Reduced clonality of proliferative T cells would suggest specific antigenic responses to fetal 
antigens. 
  An exciting and extremely novel finding of our research is the discovery, through 
transcriptomic analysis, of an upregulated response to Type 1 interferon. This pathway is 
significantly upregulated in effector memory T cells at the decidua and is something 
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previously unrecognized in T cell function at this site. The fact that this pathway is 
upregulated in the absence of known viral infection, suggests that this immune response is 
associated with classical viral infection and may be a unique identifier of T cell allo-
reactivity at the maternal-fetal interface. As discussed in Chapter 6, we can only speculate 
at this point which antigen or effector elicits this type 1 interferon response. As previously 
mentioned, the possibility of endogenous retroviral proteins on the surface of trophoblast 
such as syncytin 1, may be presented as an additional mHAG in the adaptive immune 
response.  Further weight to this argument is provided by the pathology of V.U.E. 
resembling an inflammatory response to similar villitis conditions of known pathogenic 
origin such as CMV associated chronic villitis. An important next step would be to isolate 
and analyse decidual macrophages, and to look for similar associated pathways following 
transcriptomic analysis. Given their significant role in antigen presentation, and the high 
numbers present in cases of V.U.E., establishing whether a similar response to interferon is 
present during healthy pregnancy would present an alternative pathway towards fetal allo-
reactivity.  
The presence of activated, antigen experienced T cells at the decidua in healthy 
pregnancy reinforces the emerging concept that T cells play an important role at the 
maternal-fetal interface and that fetal-specific recognition is carefully modulated by 
multiple checkpoint proteins and T regulatory cells. Dysregulation of this immune 
homeostasis has substantial implications for the development of healthy pregnancy. 
Taking into account the research undertaken in this project, Figure 7.1 outlines the various 
immunological pathways that may occur at the maternal-fetal interface. Further research 
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into this unique microenvironment and the how it is regulated will lead to a better 
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Decidual T Cells Exhibit a Highly Differentiated Phenotype
and Demonstrate Potential Fetal Specificity and a Strong
Transcriptional Response to IFN
Richard M. Powell,*,1 David Lissauer,†,1 Jennifer Tamblyn,†,‡ Andrew Beggs,x
Philip Cox,{ Paul Moss,*,2 and Mark D. Kilby†,‡,2
Immune tolerance during human pregnancy is maintained by a range of modifications to the local and systemic maternal immune
system. Lymphoid infiltration is seen at the implantation site of the fetal–maternal interface, and decidual NK cells have been
demonstrated to facilitate extravillous trophoblast invasion into maternal decidua during the first trimester, optimizing hemo-
chorial placentation. However, although there is considerable T cell infiltration of the maternal decidua, the functional properties
of this T cell response remain poorly defined. We investigated the specificity and regulation of CD4+ and CD8+ T cells obtained
from human third trimester decidua and demonstrated that decidual CD4+ and CD8+ T cells exhibit a highly differentiated
effector memory phenotype in comparison with peripheral blood and display increased production of IFN-g and IL-4. Moreover,
decidual T cells proliferated in response to fetal tissue, and depletion of T regulatory cells led to an increase in fetal-specific
proliferation. HY-specific T cells were detectable in the decidua of women with male pregnancies and were shown to be highly
differentiated. Transcriptional analysis of decidual T cells revealed a unique gene profile characterized by elevated expression of
proteins associated with the response to IFN signaling. These data have considerable importance both for the study of healthy
placentation and for the investigation of the potential importance of fetal-specific alloreactive immune responses within disorders
of pregnancy. The Journal of Immunology, 2017, 199: 3406–3417.
www.jimmunol.org/cgi/doi/10.4049/jimmunol.1700114














 
 
